POPULARITY
3 episodes with digestive diseases
5 episodes with digestive diseases
4 episodes with digestive diseases
2 episodes with digestive diseases
2 episodes with digestive diseases
2 episodes with digestive diseases
3 episodes with digestive diseases
2 episodes with digestive diseases
In this video, I debunk all the recovery myths that keep you stuck. They might seem to work temporarily, but in the long run, they are a waste of your time. Whether you have long COVID, ME/CFS, Lyme, adrenal fatigue, chronic fatigue, fibromyalgia, or MCAS, this 20-minute video will save you years of time.Join our Q&A: https://releasecfs.com/contact/ Blog: https://releasecfs.com/developing-the-cfs-personality/Time Stamps: 00:59 The myth of the magic recovery moment 01:48 The myth of the baseline and pacing 03:40 The Cell Danger Response (CDR) by Dr. Robert Naviaux 04:22 Overcomplicating your recovery and healing journey 05:01 How to simplify your condition and understand different symptoms 07:15 The myth of the false danger response 07:44 The MindBody theory and lots of research 11:57 What is the best way to heal? 14:52 Myth - There is something wrong with your body (infections, immune system, genetics, mitochondria 16:42 The myth about Brain Retraining 19:04 Myth- Different things work for different people 19:46 The 4 steps to heal in the Release Program 21:13 Myth - Calming down the nervous system 21:36 Final Thoughts and tips.
In this episode, we run the gamut from sharing health resources, pathologically delicious food vs real food, and palette formation to old food traditions and recipes. We answer the question: How important is fleeing the city and starting a homestead as a Christian family? Plus plenty of rabbit trails like the importance of the medieval pig, how conventional health is fear-based, how isolating in our family is impossible, how real food isn't debatable; it's dogma, and our general health plan. Stay tuned for episodes 106 and 107 for the details of exactly how we fought pertussis without antibiotics. Timestamps/Topics for Episode 105: 0:00 A Meatsmith's weird form of building immunity 5:08 More health resources 10:25 Pathologically delicious food vs real food, palette formation, and old food traditions and recipes 16:00 The foundation of health is your diet and nutrition 25:00 How important is fleeing the city and starting a homestead as a Christian family? 35:00 The importance of The Medieval Pig 41:40 Conventional health is fear-based & isolating in our family is impossible 46:09 Pamela Acker's work on vaccines 49:40 Our general health plan & Real food isn't debatable; it's dogma Links for Episode 105: Mommy Diagnostics (The Art of Taking Care of Your Family) by Shonda Parker. https://a.co/d/ah1BOlc Restoring Your Digestive Health: A Proven Plan to Conquer Crohn's, Colitis, and Digestive Diseases by Jordan S. Rubin N.M.D. & Joseph Brasco M.D. https://www.goodreads.com/book/show/54501760-restoring-your-digestive-health The Maker's Diet by Jordan S. Rubin N.M.D. https://www.goodreads.com/book/show/185276.The_Maker_s_Diet Aajonus Vonderplanitz https://en.wikipedia.org/wiki/Aajonus_Vonderplanitz Mrs. Beeton's Book of Household Management: The 1861 Classic with Advice on Cooking, Cleaning, Childrearing, Entertaining, and More by Isabella Beeton. https://a.co/d/1q3GF6B Jane Grigson's food books: https://www.goodreads.com/author/show/226917.Jane_Grigson?from_search=true&from_srp=true The Nordic Cookbook by Magnus Nilsson. https://a.co/d/gPnHqLm The Medieval Pig (Nature and Environment in the Middle Ages) by Dolly Jørgensen. https://a.co/d/2KC5xbz Vaccination: A Catholic Perspective by Pamela Acker M.S. https://kolbecenter.org/product/vaccination-a-catholic-perspective/ Disclaimer: We don't necessarily endorse every claim made in the interviews in the following links, but we feel they give a fair representation of narratives currently absent in conventional discourse. Resistance Podcast 68: Vaccines & the Immune System w/ Pamela Acker https://sensusfidelium.com/resistance-podcast-68-vaccines-the-immune-system-w-pamela-acker/ A Priest's Moral Analysis of the Covid "Vaccines." https://sensusfidelium.com/2021/04/09/a-priests-moral-analysis-of-the-covid-vaccines/ Resistance Podcast 143: Answers on Vaccination Concerns w/ Fr Ripperger https://rumble.com/vblh29-resistance-podcast-143-answers-on-vaccination-concerns-w-fr-ripperger.html Looking for more Meatsmith knowledge? Join our online membership or come to an in-person class: Hands-On Harvest Classes - Come to one of our harvest classes on our homestead in Oklahoma. We offer pork, beef, lamb, and goose harvest classes in the Spring and Fall. Spots are limited to just eight students per class to keep the hands-on experience undiluted. Jump on this chance and sign up today! Farmsteadmeatsmith.com/upcoming-classes/ Meatsmith Membership - We created an online community and resource for homesteaders and farmers. It serves all those who want to cook and eat well. We offer the fruit of our labors (and our kitchen) from more than fifteen years of experience, and our Membership community of more than six hundred is an invaluable digital resource. The only one of its kind in the country, Meatsmith Membership provides an earnest and winsome approach to domestic livestock raising, slaughter, butchery, curing, cookery, and charcuterie. Join today and partner with us in growing your home around the harvest. Monthly memberships are $17.49/month plus a $29.99 sign-up fee. Or purchase an Annual membership for $189.49/year with no sign-up fee, saving you $50.38. Farmsteadmeatsmith.com/membership/
Discusses the use of synthetic data in research and healthcare. Our guest today is Dennis L. Shung, MD, MHS, PhD, an Assistant Professor of Medicine at Yale School of Medicine and Director of Digital Health in Digestive Diseases. He leads the Human+Artificial Intelligence in Medicine lab, which focuses on enhancing human presence with AI. Dennis is also involved in multiple gastroenterology AI initiatives and research. Additional resources: NSF Program Solicitation on Mathematical Foundations of Digital Twins: https://new.nsf.gov/funding/opportunities/math-dt-mathematical-foundations-digital-twins/nsf24-559/solicitation AI models collapse when trained on recursively generated data: https://www.nature.com/articles/s41586-024-07566-y Synthetic data in machine learning for medicine and healthcare: https://www.nature.com/articles/s41551-021-00751-8 Synthetic data in medical research: https://bmjmedicine.bmj.com/content/1/1/e000167 Harnessing the power of synthetic data in healthcare: innovation, application, and privacy: https://www.nature.com/articles/s41746-023-00927-3 Essentials of Responsible AI: https://about.citiprogram.org/course/essentials-of-responsible-ai Big Data and Data Science Research Ethics: https://about.citiprogram.org/course/big-data-and-data-science-research-ethics/
Lin Chang, MD, Vice Chief, Vatche and Tamar Manoukian, Division of Digestive Diseases; Program Director, UCLA GI Fellowship Program; Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience; Director, Clinical Studies and Database Core, Goodman-Luskin Microbiome Center; Professor of Medicine, David Geffen School of Medicine, UCLA CME Credit Available for all Providence Providers In order to claim CME credit, please click on the following link: https://forms.office.com/r/sP9b71Dxuz (or copy & paste into your browser) Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Planning Committee & Faculty Disclosure: The planning committee has indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. Dr. Chang has indicated the following financial relationships: Scientific advisory boards or consulting (Alfasigma, Ardelyx, Arena, Atmo, Bausch Health, Food Marble, GlaxoSmithKline, Ironwood, Trellus Health); Speaker (Abbvie, Ironwood, Salix); Research grants (AnX Robotica, Arena, Ironwood); Stock options (ModifyHealth, Trellus Health, Food Marble); Rome Foundation Board of Directors All financial relationships (if any) have been mitigated. Original Date: October 8, 2024 End Date: October 8, 2025
Lin Chang, MD, Vice Chief, Vatche and Tamar Manoukian, Division of Digestive Diseases; Program Director, UCLA GI Fellowship Program; Co-Director, G. Oppenheimer Center for Neurobiology of Stress and Resilience; Director, Clinical Studies and Database Core, Goodman-Luskin Microbiome Center; Professor of Medicine, David Geffen School of Medicine, UCLA CME Credit Available for all Providence Providers In order to claim CME credit, please click on the following link: https://forms.office.com/r/sP9b71Dxuz (or copy & paste into your browser) Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Planning Committee & Faculty Disclosure: The planning committee has indicated no relevant financial relationships with an ACCME-defined ineligible company. Their planning contributions were evidence-based and unbiased. Dr. Chang has indicated the following financial relationships: Scientific advisory boards or consulting (Alfasigma, Ardelyx, Arena, Atmo, Bausch Health, Food Marble, GlaxoSmithKline, Ironwood, Trellus Health); Speaker (Abbvie, Ironwood, Salix); Research grants (AnX Robotica, Arena, Ironwood); Stock options (ModifyHealth, Trellus Health, Food Marble); Rome Foundation Board of Directors All financial relationships (if any) have been mitigated. Original Date: October 8, 2024 End Date: October 8, 2025
There is a wide range of gastrointestinal conditions, and their symptoms, severity, and types are often misunderstood. From bloating to chronic diarrhea, how do we know when to seek medical advice for something more serious? What are the various diagnoses? What are red flags to look out for? We spoke with Lin Chang, MD, gastroenterologist and vice-chief of the Vatche and Tamar Manoukian Division of Digestive Diseases at UCLA, about the steps to looking at symptoms – and when to seek help, the 8 possible domains of GI conditions, how the gut and brain interact, and advice about how to improve gut health for patients to live their best lives.
That's according to our most recent guest on Better Mojo Better Life. In this episode we sit down with Dr. Corey Howard. His diversified educational background makes him uniquely qualified for his customized brand of elite concierge medicine. His resume includes Doctor of Medicine, a psychiatry internship, internal medicine residency, a two-year advanced fellowship in Digestive Diseases and Nutrition (Gastroenterology) board certification in Anti-Aging, Functional and regenerative medicine as well as a fellowship in Metabolic Nutritional Medicine. Add to that, a life coach certification and you can see why his patients and the broader medical community are attracted to his individualized approach to healthier living. When I asked Dr. Howard how he keeps his patients motivated, his answer said it all, “in order to motivate them, first I must determine if they ARE motivated” to put in the work and follow his recommendations. His extensive experience and education play a big role in his ability to assess whether individuals are in the right space to achieve their goals. Which leads to the first question Dr. Howard asks potential patients, “What are you trying to accomplish with your health?' Most of us struggle to articulate our goals, more commonly responding with “I don't know, but I know what I don't want.” Dr. Howard's coaching often leads to self-discovery allowing patients to lock in on their underlying motivation and make the changes necessary to live longer, healthier lives. Finally, Dr. Howard is not shy about his individual vs. population model of healthcare. He's not for everyone and that's ok. Bonus: he is also an author, a health policy advocate and all-around cool guy. Great listen.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Benjamin Schmidt, MD It's become clear that social media is here to stay, and it's become a way that people get their information and spread information. Dive into this episode to learn about the benefits and challenges of social media in healthcare from a recently published article with Dr. Peter Buch and Dr. Benjamin Schmidt, Gastroenterologist at Esse Health in St. Louis, Missouri. He's also the author of the article, titled “How a GI Fellow Found a Following: Harnessing the Power of Social Media for Education and Fun,” which was published in Digestive Diseases and Sciences in 2023.
News
Josh is an ex-paramedic, and Holistic Nutritionist, specializing in gut health. ======= Thanks to my Sponsors : If you or know some body you know is struggling with anxiety and want to know how to be 100% anxiety free, in 6 weeks, without therapy or drugs, fully guaranteed - then let me tell you about our sponsor Daniel Packard. Watch this Free 45 min. Training to learn an innovative technique that: a) Quickly lowers your anxiety by up to 85% b) Proves solving your anxiety can be simple. https://www.danielpackard.com/ -------------------------- Do you have High Blood Pressure and/ or want to get off the Meds Doctors are amazed at what the Zona Plus can do $50 Discount with my Code ROY https://www.zona.com/discount/ROY ------ Speaking Podcast Social Media / Coaching My Other Podcasts https://bio.link/podcaster ============ About Josh Dech : Josh is an ex-paramedic, and Holistic Nutritionist, specializing in gut health. It was the successes his clients have had with complex digestive diseases, previously thought to be impossible, that got him connected to some of the world's most renowned doctors. Since then, he's been recruited to the Priority Health Academy as a medical lecturer, helping educate doctors on the holistic approach to gut health, and complex digestive issues. It was the successes his clients have had with complex digestive diseases, previously thought to be impossible, that got him connected to some of the world's most renowned doctors. Since then, he's been recruited to the Priority Health Academy as a medical lecturer, helping educate doctors on the holistic approach to gut health, and complex digestive issues. What we Discussed: - Who is Josh Dech( 1:30 mins) - Preparing for being a Paramedic ( 2 mins) - Whe he got into Health Care ( 3 mins) - The Western Medical System not looking at root cause ( 6 mins) - Different IBS Issues ( 7 mins) - The neuros in the Gut ( 10 mins) - Mindful Eating ( 12 mins) - Food Combining (15:45mins) - Natural Birth a lot better than a section (17 mins) - Antibiotics Killing the Good Bacteria (21:45 mins) - Mold Infection in the Gut (25:30mins) - Sound Frequencies to heal ( 28 mins) - Exercise (32 mins) - The Corrupt Food System ( 33 mins) - His Podcast Reversable ( 36 mins) - Sevice Guarantee for his services ( 38 mins) - What things to do for improving your Gut ( 39 mins) - Should you eat food according to your Blood Type (42 mins) and more ==================== How to Contact Josh Dech : https://www.reversablepod.com free content/programs: https://www.reversablepod.com/free https://www.facebook.com/joshdech.health https://www.instagram.com/joshdech.health/ =============== Donations https://www.podpage.com/speaking-podcast/support/ Speaking Podcast Social Media / Coaching My Other Podcasts https://bio.link/podcaster
Josh is an ex-paramedic, and Holistic Nutritionist, specializing in gut health. ======= Thanks to my Sponsors : If you or know some body you know is struggling with anxiety and want to know how to be 100% anxiety free, in 6 weeks, without therapy or drugs, fully guaranteed - then let me tell you about our sponsor Daniel Packard. Watch this Free 45 min. Training to learn an innovative technique that: a) Quickly lowers your anxiety by up to 85% b) Proves solving your anxiety can be simple. https://www.danielpackard.com/ -------------------------- Do you have High Blood Pressure and/ or want to get off the Meds Doctors are amazed at what the Zona Plus can do $50 Discount with my Code ROY https://www.zona.com/discount/ROY ------ Speaking Podcast Social Media / Coaching My Other Podcasts https://bio.link/podcaster ============ About Josh Dech : Josh is an ex-paramedic, and Holistic Nutritionist, specializing in gut health. It was the successes his clients have had with complex digestive diseases, previously thought to be impossible, that got him connected to some of the world's most renowned doctors. Since then, he's been recruited to the Priority Health Academy as a medical lecturer, helping educate doctors on the holistic approach to gut health, and complex digestive issues. It was the successes his clients have had with complex digestive diseases, previously thought to be impossible, that got him connected to some of the world's most renowned doctors. Since then, he's been recruited to the Priority Health Academy as a medical lecturer, helping educate doctors on the holistic approach to gut health, and complex digestive issues. What we Discussed: - Who is Josh Dech( 1:30 mins) - Preparing for being a Paramedic ( 2 mins) - Whe he got into Health Care ( 3 mins) - The Western Medical System not looking at root cause ( 6 mins) - Different IBS Issues ( 7 mins) - The neuros in the Gut ( 10 mins) - Mindful Eating ( 12 mins) - Food Combining (15:45mins) - Natural Birth a lot better than a section (17 mins) - Antibiotics Killing the Good Bacteria (21:45 mins) - Mold Infection in the Gut (25:30mins) - Sound Frequencies to heal ( 28 mins) - Exercise (32 mins) - The Corrupt Food System ( 33 mins) - His Podcast Reversable ( 36 mins) - Sevice Guarantee for his services ( 38 mins) - What things to do for improving your Gut ( 39 mins) - Should you eat food according to your Blood Type (42 mins) and more ==================== How to Contact Josh Dech : https://www.reversablepod.com free content/programs: https://www.reversablepod.com/free https://www.facebook.com/joshdech.health https://www.instagram.com/joshdech.health/ =============== Donations https://www.podpage.com/speaking-podcast/support/ Speaking Podcast Social Media / Coaching My Other Podcasts https://bio.link/podcaster --- Send in a voice message: https://podcasters.spotify.com/pod/show/roy-coughlan/message
One of the top-trending health-related questions searched on Google in 2023 was "What helps with bloating?" Listen in this week as Dee provides insight into why bloating is such a common problem and what you can do to improve digestion and stop the bloat!Link to Purchase Digestive Enzymes: https://amzn.to/3DBV9ORReference: Di Stefano, M., Miceli, E., Gotti, S., Missanelli, A., Mazzocchi, S., & Corazza, G. R. (2007). The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms. Digestive Diseases and Sciences, 52(1), 78–83. https://pubmed.ncbi.nlm.nih.gov/17151807/
In this episode I talk with Dr. Mark Pimentel, a leader in the small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS) world. We talk about what his team is doing to push research forward for SIBO and IBS, new developments in SIBO, breath testing and gasses produced, as well as things that will be coming out soon for treatment. In this episode, we cover: What is SIBO [4:29] What the team is working on [5:46] Keeping an open mind as a scientist [9:02] The controversy of breath testing [10:01] Hydrogen sulfide [13:24] This episode is sponsored by FODZYME, the world's first enzyme blend that targets FODMAPs, gas-causing carbohydrates and common gut triggers. Mixing FODZYME with your food allows the enzymes to integrate and break down the FODMAPs lactose, GOS, and fructan, before they can affect your gut. Through a unique formula and powder form for maximum efficacy, FODZYME can help you reduce overall FODMAP load, support better digestion and enable nutritional diversity for optimal health. Say goodbye to digestion drama with the help of FODZYME. Learn more at fodzyme.com and use code GUTSHOW at checkout to save 20% off any single order Mentioned in this episode: REIMAGINE Study: https://csmast.com/current-research/ Breath testing for SIBO and IMO: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496284/ Research articles from the MAST team: https://csmast.com/scientific-articles/ Indian consensus statements on IBS: https://pubmed.ncbi.nlm.nih.gov/36961659/ Join the MASTER Method Membership: https://www.ibsmastermethod.com/master-method About our guest: Mark Pimentel, MD, is a Professor of Medicine at Cedars-Sinai. Dr. Pimentel is also the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, an enterprise of physicians and researchers dedicated to the study of the gut microbiome in order to develop effective diagnostic tools and therapies to improve patient care. Dr. Pimentel is also a Professor of Medicine at the Geffen School of Medicine, University of California, Los Angeles (UCLA.) As a physician and researcher, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical investigations of irritable bowel syndrome (IBS) and the relationship between gut flora composition and human disease. This research led to the first ever blood tests for IBS, ibs-smartTM, the only licensed and patented serologic diagnostic for irritable bowel syndrome. The test measures the levels of two validated IBS biomarkers, anti-CdtB and anti-vinculin. A pioneering expert in IBS, Dr. Pimentel's work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others. Dr. Pimentel has presented at national and international medical conferences and advisory boards. He is a diplomate of the American Board of Internal Medicine (Gastroenterology,) a fellow of the Royal College of Physicians and Surgeons of Canada and a member of the American Gastroenterological Association, the American College of Gastroenterology, and the American Neurogastroenterology and Motility Society. Learn more about Dr. Pimentel's work: https://www.cedars-sinai.org/research/areas/science-tech.html Twitter: https://twitter.com/MASTprogram Instagram: @mastprogram Connect with Erin & the Gutivate team: IG: @erinjudge.rd or @gutivate Website: www.gutivate.com Schedule a consult: bit.ly/gutivateconsult FREE: IBS Fundamentals Mini Course: https://www.ibsmastermethod.com/ibs-fundamentals-sign-up Join The GUT Community: The Facebook group for those with IBS and digestive health conditions to connect, encourage one another, and dive deeper into the topics we cover on The Gut Show. Join here: https://www.facebook.com/groups/thegutcommunity Track your symptoms & understand your body better: My Gut Journal is a 90 day gut tracker to build awareness in your mind & body. Get yours at https://gutivate.com/store/mygutjournal
In this podcast episode, Anita Afzali, MD, MPH, MHCM, FACG, AGAF, and Aja McCutchen, MD, discuss how women in gastroenterology (GI) can embrace and enhance their value. These inspiring GI medicine experts propose a practical formula that involves ongoing, careful self-reflection and asking yourself how your strengths, core values, and interests can be aligned with professional endeavors. In addition, self-advocacy and self-allyship can serve as harmonious tools to drive action and positive change. Presenters:Dr Anita Afzali is a Professor of Clinical Medicine, Interim Division Director of the Division of Digestive Diseases, Executive Vice Chair of Medicine in the Department of Internal Medicine, and the Associate Chief Medical Officer of the UC Health system in Cincinnati, Ohio. She is also a Co-Founder of Scrubs & Heels.Anita Afzali, MD, MPH, MHCM, FACG, AGAF: consultant: AbbVie, Bristol Myers Squibb, Gilead Sciences, Janssen, Lilly, Pfizer, Takeda; provider of non-CME/CE services: AbbVie, Janssen, Pfizer, Takeda.Dr Aja McCutchen is a Partner and Physician Executive at Atlanta Gastroenterology Associates, a division of United Digestive in Atlanta, Georgia, and served as Co-Chair at the Scrubs & Heels 2023 Leadership Summit. Aja McCutchen, MD: consultant/advisor/speaker: Eli Lilly, Modify Health, Redhill Biopharm, Sanofi Regeneron, Takeda.Episode outline: Understanding and establishing your own market value; bringing that to your own organizationConsequences of being ill-equipped to pursue professional growth and developmentAdvocating for the value you bring to the professionNegotiation as a form of self-allyshipNegotiation categories to help support career success and protect work–life balanceOther program activities: Full Program: Equipped and Empowered: Thriving as Women in GIPodcast 1: Finding Your Friendtors: Mentors, Sponsors, and AlliesPodcast 3: Being Your Full Self: Pursuing Work–Life BalanceClinicalThought: Expert Commentary on Thriving as Women in GITo receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select 1 best answer for each question. When you have completed all the questions, press the "Continue" button at the bottom.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Suijit Janardhan, MD, PhD Diabetic patients have a significant risk for developing more advanced liver disease, and the disease that they're particularly at risk for is steatotic liver disease. Dive into this episode to learn more with Dr. Charles Turck and Dr. Sujit Janardhan, Assistant Professor in the Department of Internal Medicine, Division of Digestive Diseases and Nutrition, and the Department of Transplant Surgery at Rush University Medical Center in Chicago.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Suijit Janardhan, MD, PhD Diabetic patients have a significant risk for developing more advanced liver disease, and the disease that they're particularly at risk for is steatotic liver disease. Dive into this episode to learn more with Dr. Charles Turck and Dr. Sujit Janardhan, Assistant Professor in the Department of Internal Medicine, Division of Digestive Diseases and Nutrition, and the Department of Transplant Surgery at Rush University Medical Center in Chicago.
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Suijit Janardhan, MD, PhD Diabetic patients have a significant risk for developing more advanced liver disease, and the disease that they're particularly at risk for is steatotic liver disease. Dive into this episode to learn more with Dr. Charles Turck and Dr. Sujit Janardhan, Assistant Professor in the Department of Internal Medicine, Division of Digestive Diseases and Nutrition, and the Department of Transplant Surgery at Rush University Medical Center in Chicago.
An exclusive with Prof. Yaw Asante Awuku - Head Department Of Medicine, University of Health and Allied Sciences (UHAS) on Liver & Digestive Diseases
In this episode, we interview two guests, Dr. Guadalupe Garcia Tsao and Dr. Andrew Yu. Dr. Yu is the Emory transplant Hepatology fellow currently. We discuss the Baveno VII guidelines on Portal Hypertension and some major takeaways from #TLM or the American Association for the Study of Liver Diseases (AASLD) meeting in Washington D.C. Dr. Guadalupe Garcia Tsao is a Professor of Medicine at Yale University School of Medicine and Chief of Digestive Diseases at the VA-Connecticut Healthcare System. She also serves as director of the Clinical Core of the NIH-funded Yale Liver Center and is the Associate Editor of the New England Journal of Medicine. She was president of AASLD in 2012. FIB4+ Scoring Algorithm - http://fib4plus.com/ Host: Dr. Chuma Obineme (GI Fellow) – https://twitter.com/TypicallySilent Co-Host: Jason Brown - https://med.emory.edu/directory/profile/?u=JMBROW2 Guest: Guadalupe Garcia-Tsao - https://twitter.com/ggarciatsao https://medicine.yale.edu/profile/guadalupe-garcia-tsao/ Guest: Andrew Yu - https://twitter.com/michaelandrewyu Link to Review: https://www.sciencedirect.com/science/article/pii/S0168827821022996 Link to Emorid Digest visual Summary: https://med.emory.edu/departments/medicine/_documents/yu-preventing-decompensation-in-cirrhosis-tips-from-baveno-vii.pdf Link to Emoroid Digest Website: https://med.emory.edu/departments/medicine/divisions/digestive-diseases/education/emoroid-digest.html
This video features Dr. Lindsey Russell, a new associate staff and gastroenterologist at the Department of Gastroenterology, Hepatology & Nutrition and the Digestive Diseases & Surgery Institute at the Cleveland Clinic. As an early-career physician, Dr. Russell shares how mentors and sponsors helped propel her career. She credits the ASPEN Global PN Fellowship supported Baxter for opening the doors for her and introducing her to ASPEN. She encourages others to get involved in ASPEN which offers great opportunities to meet and learn from experts in the field working across the spectrum of care. Physician Spotlight is a forum for outstanding Senior Leaders, Young Rising Stars, and International Colleagues in the field of nutrition to discuss important topics and ideas that impact patient care. Visit the ASPEN Physician Community at www.nutritioncare.org/physicians February 2022
We have historically thought about weight as the mere outcome of our deliberate choices about diet and exercise. We have not typically thought about weight like a disease. But in the past 18 months, there's been an extraordinary revolution in weight-loss medication that's putting in our hands a therapy that can help people easily shed weight without major side effects. You may have heard these drugs go by the name Wegovy or Ozempic. What happens when you take a country obsessed with self-image and diet and tell them that the mystery of weight loss has now been reduced to a daily injection? You change a lot more than body mass index. You change society. Today's guest is Susan Z. Yanovski. She is the co-director of the Office of Obesity Research and the program director of the Division of Digestive Diseases and Nutrition at NIH. We talk about the stakes of anti-obesity medication, why diet and exercise doesn't work for so many people, how these weight-loss drugs could help American health care, strain American insurance, and revolutionize America's sense of willpower, responsibility, and diet. Host: Derek Thompson Guest: Susan Z. Yanovski Producer: Devon Manze Learn more about your ad choices. Visit podcastchoices.com/adchoices
Listen as Dr. Richard Manfready, Instructor in Medicine in Digestive Diseases at Rush University Medical Center, shares the gut-brain connection in Parkinson's Disease. Dr. Manfready elaborates on his research that has him working backwards in a remarkable way. He has taken the known factors about Parkinson's – loss of dopamine producing cells due to misfolded proteins - and has notably taken a step back from there. By finding that inflammation can cause proteins to misfold, and working backward, he's asked the question: what causes the inflammation? Listen as he comments on what he's finding as a reason for this disease-inducing inflammation.
In this episode I welcome on one of my hero's in medicine, Dr. Mark Pimentel. Without hesitation, he changed my career trajectory for the better when I first came across his work in 2007. Since then he has been a mentor, adviser, and educator of me as I have dedicated myself to helping patients dealing with Irritable Bowel syndrome, Small Intestinal Bacterial Overgrowth, and Intestinal Methanogen Overgrowth. We covered so many amazing topics in this episode including: Highlights from the last 5 years of Dr. Pimentel's research His career trajectory from IBS starting as a psychosomatic disorder to know a disorder with a defined pathophysiology The latest 2021-22 research that identified the key microbes involved with hydrogen overgrowth sibo, intestinal methanogen overgrowth, and hydrogen sulfide overgrowth The role of bile acids in Irritable bowel syndrome The role of stomach acid in IBS/SIBO/IMO The role of the migrating motor complex in IBS Post-infectious Irritable bowel syndrome What makes a good GI Doctor the Medically Associated Science and Technology Program (MAST) at Cedar Sinai and more. about Dr. Pimentel: Mark Pimentel, MD, FRCP (Fellows of the Royal College of Physicians – Canada) Mark Pimentel, MD, is a Professor of Medicine at Cedars-Sinai. Dr. Pimentel is also the Executive Director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, an enterprise of physicians and researchers dedicated to the study of the gut microbiome in order to develop effective diagnostic tools and therapies to improve patient care. Dr. Pimentel is also a Professor of Medicine at the Geffen School of Medicine, University of California, Los Angeles (UCLA.) As a physician and researcher, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical investigations of irritable bowel syndrome (IBS) and the relationship between gut flora composition and human disease. This research led to the first ever blood tests for IBS, ibs-smart™, the only licensed and patented serologic diagnostic for irritable bowel syndrome. The test measures the levels of two validated IBS biomarkers, anti-CdtB and anti-vinculin. A pioneering expert in IBS, Dr. Pimentel's work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others. Dr. Pimentel has presented at national and international medical conferences and advisory boards. He is a diplomate of the American Board of Internal Medicine (Gastroenterology,) a fellow of the Royal College of Physicians and Surgeons of Canada and a member of the American Gastroenterological Association, the American College of Gastroenterology, and the American Neurogastroenterology and Motility Society. Dr. Pimentel completed 3 years of an undergraduate degree in honors microbiology and biochemistry at the University of Manitoba, Canada. This was followed by his medical degree, and his BSc (Med) from the University of Manitoba Health Sciences Center in Winnipeg, Manitoba, Canada, where he also completed a residency in internal medicine. His medical training includes a fellowship in gastroenterology at the UCLA Affiliated Training Program. papers referenced https://journals.lww.com/ajg/pages/articleviewer.aspx?year=2022&issue=12000&article=00029&type=Fulltext https://pubmed.ncbi.nlm.nih.gov/33534012/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145321/ #ibs #sibo #imo #irritablebowelsyndrome #dysbiosis
Episode 26: Inflammation and GrainsThis week's episode is about grains and inflammation. I would venture to say the worst part about the holiday season is not so much the overeating, but what is on the menu. Sure, you can be derailed with a weight gain, but more importantly, you are derailed because of how you feel. You might feel bloated, your joints might hurt or you might just feel a general malaise. These are more because of the foods we eat during the holiday season – the breads, crackers, cakes and cookies – than the quantity of food we eat. This episode will tell you how you can eat smarter – not less – during the upcoming holidays. 1:11. Personal Story3:00. What is inflammation?3:42. Acute inflammation4:31. Chronic inflammation5:23. The inflammation-grains connection7:00. What are grains?7:45. Whole grains vs. refined grains10:09. General gut health11:42. What is leaky gut?13:11. Grainflammation13:41. The other side of the story14:51. Carbohydrates in grains, rice and legumes17:10. The bottom line19:00. What mistakes are we making and why?21:16. What is the cost of making these mistakes?22:30. This weeks actionable COACHING ADVICE24:26. This week's VFO (Valuable Free Offer)25:20. Episode 27, coming upBook: Breaking Free From Diet Prison Course: Breaking Free From Diet Prison Instagram@Roadmap To Diet SuccessBreaking Free Facebook PageThis week's VFO: Five Steps out of Diet Prison and the Four Lists You NeedAccess Transcript HereBLOG: Three Ways to Count CarbohydratesLINKS TO STUDIES IN THIS EPISODE:John Hopkins Study: https://www.hopkinsmedicine.org/health/wellness-and-prevention/fight-inflammation-to-help-prevent-heart-diseaseDennis Thompson Article: https://consumer.healthday.com/vitamins-and-nutrition-information-27/dieting-to-increase-fiber-health-news-194/is-it-really-whole-grain-food-labels-often-misleading-760225.htmlPeter Osborne: Grainflammationhttps://www.glutenfreesociety.org/grainflammation-how-grains-cause-inflammation/Columbia University Studyhttps://gut.bmj.com/content/65/12/1930.fullDr. Armin Aldinihttps://www.cuimc.columbia.edu/news/columbia-researchers-find-biological-explanation-wheat-sensitivity-0Global Journal of Digestive Diseases
#254 Mark Pimentel, is Professor of Medicine at Geffen School of Medicine and Cedars-Sinai Medical Center in Los Angeles. He is also the Executive Director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai Medical Center. Dr. Pimentel completed 3 years of an undergraduate degree in honors microbiology and biochemistry. This was followed by his medical degree, and his BSc (Med) from the University of Manitoba Health Sciences Center, where he also completed a residency in internal medicine. His medical training includes a fellowship in gastroenterology at the UCLA Affiliated Training Program. Active in research, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical studies in such areas as IBS, and the relationship between gut flora composition and human disease. His work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others. Dr. Pimentel is a diplomate of the American Board of Internal Medicine (Gastroenterology) and a fellow of the Royal College of Physicians and Surgeons of Canada. In this episode we cover Exciting new developments with SIBO research What the research says on PPI's increasing the risk of SIBO Current treatment for hydrogen sulphide treatment Why methane overgrowth (IMO) is so stubborn to treat Sibo diet post active treatment - how long to keep people on it The impact of ageing on the small intestine and the link between Scleroderma and antivinculin antibodies The preferred substrate for SIBO breath testing The Microbiome Connection book And so much more
Amore for Amari! Bittered spirits loaded with botanicals have a long history rooted (pun intended) in medicine. This episode explores some of the foundations and culture behind bittered spirits. Resources from this episode: Books: Bitters: A Spirited History of a Classic Cure-All, Parsons, B. T., 2011 Certified Specialist of Spirits (CSS) Study Guide (Society of Wine Educators), Nickles, J., (2020) The Drunken Botanist: The plants that create the world's great drinks. Stewart, A. (2013) The Oxford Companion to Spirits and Cocktails [Kindle Edition], Wondrich, D & Rothbaum, N., (2022) Websites: The Amaro List: What is Amaro? Parsons, B. T. (n.d.) https://www.amarolist.com/what-is-amaro Amaro Montenegro US: Our Story https://amaromontenegro.us/our-story Chartreuse: History of Chartreuse https://www.chartreuse.fr/en/story/ Dictionary.com: Carminative https://www.dictionary.com/browse/carminative The Spruce Eats: What is Bénédictine D.O.M. Liqueur?, Graham, C. (23 July 2021) https://www.thespruceeats.com/benedictine-d-o-m-liqueur-760249 Journal Articles: National Library of Medicine, National Center for Biotechnology Information: The Efficacy of an Herbal Medicine, Carmint, on the Relief of Abdominal Pain and Bloating in Patients with Irritable Bowel Syndrome - A Pilot Study, Vejdani et. Al, [Digestive Diseases and Sciences, Vol 51, pp. 1501 - 1507] (2006) https://pubmed.ncbi.nlm.nih.gov/16868824/ Glass in Session® Episodes Mentioned in this Session: S10E3: Getting Our Grappa On https://glassinsession.libsyn.com/s10e3-getting-our-grappa-on S8E3: Let's Absinthe https://glassinsession.libsyn.com/s8e4-lets-absinthe S5E3: Liqueur Lexicon https://glassinsession.libsyn.com/s5e3-liqueur-lexicon S1E2: Aperitif Wines https://glassinsession.libsyn.com/s1e2-aperitif-wines Glass in Session® is a registered trademark of Vino With Val, LLC. Music: “Write Your Story” by Joystock (Jamendo.com cc_Standard License, Jamendo S.A.)
This week we discuss the CANDID meeting: Consortium for Autism, Neurodevelopmental Disorders and Digestive Diseases, what was shared, what was learned, and where doctors and researchers need to do more. They included the link between the brain-gut connection, challenges in diagnosis, ongoing studies, potential solutions, and what pediatric gastroenterologists need to know about helping families … Continue reading "Let's talk about poop"
IBS is a frustrating and difficult illness to understand.IBS is a frustrating and difficult illness to understand. But our guest led research to the first-ever blood tests for IBS, with ibs-smart®, the only licensed and patented serologic diagnostic for IBS. Mark Pimentel, MD, FRCP(C) is a professor of medicine and gastroenterology at Geffen School of Medicine UCLA and associate professor of medicine at Cedars-Sinai, Los Angeles. He is also the head of the Pimentel Laboratory and the executive director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai in Los Angeles and joins Marsha today to talk all about his groundbreaking research.Dr. Pimentel's decades of pioneering gastroenterological research led him to develop the Low Fermentation Eating (LFE) diet to help SIBO sufferers enjoy a less restrictive diet and lifestyle.A pioneering expert in irritable bowel syndrome (IBS), Dr. Pimentel's work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others.
Welcome to another Episode of Talking Gut, and today I have the honour of presenting someone a person I deeply respect, Prof Lin Chang. I met prof Chang many years ago while she was visiting Melbourne to present at ANGMA, The Australasian Neurogastroenterolgy and Motility Association conference, and again during DDW conference in Chicago and San Diego. Please allow me to introduce Prof Chang Lin Chang, MD is a Professor of Medicine and Vice-Chief of the Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine at the David Geffen School of Medicine at UCLA. She serves as the Co-Director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience at UCLA. She is also Program Director of the UCLA Gastroenterology Fellowship Program. Dr. Chang's clinical and research expertise is in disorders of brain-gut disorders. Her research focuses on the pathophysiology of IBS related to stress, early life adversity, sex differences, and epigenetic factors, and the treatment of IBS. She is currently the Clinical Research Councilor of the AGA Governing Board. She previously served as President of the American Neurogastroenterology and Motility Society (ANMS) and is a member of the Rome Foundation Board of Directors. So…todays talk is about Stress and the Gut We all know stress affects the gut, but how does it all work. Some things you may know, but Im sure you are going to learn so much more. We cover everything from how stress affects the gut from a neurobiological perspective, to how stress affects the microbiota,. There is just so much more and I just want to jump straight into it! Lets go! Please enjoy my conversation with Prof Lin Chang
Loren Laine, MD, professor of Medicine (Digestive Diseases); chief, Section of Digestive Diseases, Internal Medicine; medical chief, Digestive Health, Yale New Haven Health, discusses the pandemic-related decline in colorectal cancer screening, racial and ethnic disparities in cancer care and survival, and other research highlights from the recent Digestive Disease Week meeting. Related Content: Highlights From Digestive Disease Week—Pandemic-Related Decline in Colorectal Cancer Screening, Lack of Association Between Proton Pump Inhibitors and Dementia, and More
Dr Ali Rezaie MD, MSc, FRCPC is a gastroenterologist who has dedicated his career to understanding irritable bowel syndrome, gut microbiome and internal UV therapy. He has published over 100 research articles in peer-reviewed journals including Gastroenterology, American Journal of Gastroenterology, Digestive Diseases and Sciences and Canadian Journal of Gastroenterology. His works have been cited more than 6,000 times by other scientific journals. Dr. Rezaie serves as the associate editor of the Journal of Digestive Disease and Sciences. Dr Ali is an associate professor at Cedars-Sinai and an associate clinical professor at UCLA. Dr. Rezaie also serves as the director of Bioinformatics and Biotechnology for the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai. He is also the author of “The Microbiome Connection: Your Guide to IBS, SIBO and Low Fermentation Eating”. Krystyna Houser is the founder of Good LFE. A busy mom of three living in Brooklyn, NY. Her journey of Small Intestinal Bacterial Overgrowth (SIBO) diagnosis and treatment took several years and inspired her to create Good LFE, a multifaceted product and lifestyle brand focusing on microbiome health and wellness for those struggling with SIBO and IBS. She bravely refused to take the standard antibiotic regiment for SIBO, took responsibility for her own health and body and ultimately conquering SIBO by making the food changes her body needed. Join us as we explore:The power of low fermentation eating in changing people's lives by healing their gut.Krystyna's SIBO story, and how that led her to collaborating with Dr Ali on bringing attention to low fermentation eating. How IBS is one of the many diseases once considered ‘just in the patient's head' that has now been proven to be an issue of gut dysbiosis despite major resistance from the medical field.A deep, technical dive into what causes SIBO and IBS, including incredible new treatments like herbal antibioticsHow to get correctly tested and diagnosed. Spoiler – be careful of DIY tests!The critical difference between low fermentation eating and Low FODMAP.Life changing guidance anyone can begin today to get on the path of healing SIBO or IBS from true world experts.Contact:Website - https://bio.cedars-sinai.org/rezaiea/index.htmlMentions:Book - The Microbiome Connection: Your Guide to IBS, SIBO and Low Fermentation Eating, https://www.amazon.com/Microbiome-Connection-Guide-Fermentation-Eating/dp/1572843098Book – The Good LFE Cookbook – Low Fermentation Eating for SIBO, Gut Health and Microbiome Balance, https://www.amazon.com/The-Good-LFE-Cookbook/dp/1572843071Schedule a FREE 15 min discovery call with Steve and let's get started on your journey to thriving: https://bit.ly/3BcTsFwSUPPORT THE SHOW ON PATREON:As much as we love doing it, there are costs involved and any contribution will allow us to keep going and keep finding the best guests in the world to share their health expertise with you. I'd be grateful and feel so blessed by your support: https://www.patreon.com/MadeToThriveShowCONTACT Steve Stavs and join our community:https://www.facebook.com/MadeToThriveZA/ https://www.facebook.com/SteveStavsZA/https://www.instagram.com/stevestavsza/ Send me a WhatsApp to +27 64 871 0308. Disclaimer: Please see the link for our disclaimer policy for all of our vide
In this podcast episode, Lin Chang, MD, vice-chief of Vatche and Tamar Manoukian Division of Digestive Diseases, discusses her path to GI, her interest in IBS and some of the newest therapies coming down the pipe and more. Intro :02 Welcome to this episode of Gut Talk :22 About Chang :28 The interview :46 Where did you grow up? :49 Who are your early role models? 3:50 How far along in college were you before you decided to apply for medical school? 4:58 How did you get interested in GI? 5:32 What advice would you give to the residents and fellows that you interact with in that regard? 8:42 As you started your career you weren't necessarily thinking that you were going to be a clinical/academic icon … didn't you start mostly as a clinician? 11:56 Early on when we started working together … you were the only woman in the room. How were you able to break through that glass ceiling and get into the room? 17:38 What advice do you give your fellows who want to get more involved? 22:12 How did you get interested in a condition like IBS? 24:02 Could you explain to our listeners what it means by the biopsychosocial model when referring to IBS? 26:21 Do you think that, in actuality, these could be completely separate diseases? 29:03 Discussion on the layers of IBS 32:26 Do you mind summarizing your key takeaways from an American Gastrological Association clinical practice update on the role of diet in patients with IBS? 38:03 Another document we're working on right now is the first joint society (AGA, ACG) clinical practice guideline on treatment of chronic constipation … would you like to say a couple words about that one? 42:04 What does your future look like? What are you thinking is next for Lin Chang? 44:39 In your role as program director, what are the trends that you've noticed amongst trainees? 46:46 What are you most excited about with regards to the newer therapies and treatment paradigms, the new care delivery models that are on the horizon to help patients with IBS? 49:13 Lin, this has been a great discussion 51:00 Thanks for listening 51:37 Lin Chang, MD, is the vice-chief of Vatche and Tamar Manoukian Division of Digestive Diseases, program director of the UCLA GI Fellowship Program and the co-director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience. We'd love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on Twitter @HealioGastro @sameerkberry @umfoodoc Disclosures: Berry and Chey report no relevant financial disclosures. Chang reports no relevant financial disclosures.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Hetal A. Karsan, MD, FACG, FAASLD, FASGE, FACP Primary biliary cholangitis, which was formerly known as primary biliary cirrhosis, is a chronic disease that progresses over time. Fortunately, much progress has been made in that many patients are being diagnosed and treated much earlier than before. But what exactly has changed when it comes to our detection and treatment of this disease? Dr. Peter Buch is joined by Dr. Hetal Karsan, Adjunct Professor of Medicine in the Division of Digestive Diseases at Emory University School of Medicine, to discuss key updates in primary biliary cholangitis care.
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Hetal A. Karsan, MD, FACG, FAASLD, FASGE, FACP Primary biliary cholangitis, which was formerly known as primary biliary cirrhosis, is a chronic disease that progresses over time. Fortunately, much progress has been made in that many patients are being diagnosed and treated much earlier than before. But what exactly has changed when it comes to our detection and treatment of this disease? Dr. Peter Buch is joined by Dr. Hetal Karsan, Adjunct Professor of Medicine in the Division of Digestive Diseases at Emory University School of Medicine, to discuss key updates in primary biliary cholangitis care.
Episode 3 of this series features Anna Cristina L. dela Cruz, MD, in conversation with patient Melody Cheng about Melody's decision to start hepatitis B virus (HBV) antiviral therapy during pregnancy. This podcast also discusses recommended approaches to preventing HBV transmission from mother to child, current recommendations on starting treatment for chronic HBV infection, and the issues around stopping treatment.Presenter:Anna Christina L. dela Cruz, MDAssociate ProfessorDivision of Digestive Diseases and NutritionDepartment of Internal MedicineUniversity of KentuckyLexington, KentuckyContent based on an online CME program supported by independent educational grants from AbbVie and Gilead Sciences.Link to full program: https://bit.ly/3KmJvZt
How is IBD different in kids than it is in adults? When should kids be transitioned from pediatric to adult care? What's next for IBD treatments? My guest is Dr Jeffrey Hyams, the head of the Division of Digestive Diseases, Hepatology and Nutrition at Connecticut Children's, and a Professor of Pediatrics at the University of Connecticut School of Medicine. He provides a historical perspective on the treatment of IBD and is able to highlight how therapies have advanced over the last 30 years. He also gives some ideas about what's on the horizon for IBD treatments and what gives him hope for the future. Concepts discussed on this episode include: How IBD Affects Growth in Kids and Teens Managing Ulcerative Colitis in Children Bradley S. Jerson, PhD, Pediatric Psychologist, who appeared on Episode 77, Episode 78, and Episode 99 Comparing 6 Biologic Drugs Used to Treat IBD Find a transcript and more at: https://bit.ly/AIBD106 Find Amber J Tresca at AboutIBD.com, Verywell, Facebook, Twitter, Pinterest, and Instagram. Credits: Mix and sound design is by Mac Cooney. Theme music, "IBD Dance Party," is from ©Cooney Studio.
Dr. James Boyer, MD, is the Ensign Professor of Medicine in Digestive Diseases and the Emeritus Director of the Liver Center at Yale School of Medicine. He earned his Bachelor's degree from Haverford College and his MD from Johns Hopkins School of Medicine, followed by internal medicine residency at Cornell and Yale and a Fellowship in hepatology at Yale. Today he shares his personal and professional story, from his formative scientific experiences in Calcutta, to his foundational discoveries in biliary formation, secretion, and cholestasis, to his work as the founding Director of the NIDDK-funded liver center at Yale, and his continuing efforts to educate and inspire young scientists interested in gastroenterology and hepatology. Credits: Our deepest thanks to Dr. Boyer for joining us today! Dr. Boyer's Faculty Page: https://medicine.yale.edu/profile/james_boyer/ Host: Bejan Saeedi Co-Host and Audio Engineer – Joe Behnke Executive Producer and Social Media Coordinator – Carey Jansen Executive Producer – Michael Sayegh Faculty Advisor – Dr. Brian Robinson Twitter: @behindthescope_ Instagram: @behindthemicroscopepod Facebook: @behindthemicroscope1 Website: behindthemicroscope.com
The back to school period is already a time of so much change but once again in this pandemic, parents and school systems are also facing difficult choices. The experiences of families during the pandemic has been diverse, which means that individual needs need to be addressed. But how do we manage that? Dr Brad Jerson Pediatric Psychologist in the Division of Digestive Diseases, Hepatology, and Nutrition at Connecticut Children's, puts some framing around these issues and how we might approach them. Topics discussed include making the decision to go back to school in the building, 504 plans for kids with digestive conditions, and helping kids to transition to school in a difficult atmosphere. Concepts discussed on this episode: 8 Tips to Help Kids With Special Needs Adjust to a New School Year What to Do When Your Child or Teen Doesn't Want to Go Back to School What Should Parents Know About the Delta Variant, Kids and Back to School? How to Check On Your Child's Mental Health Find Dr Brad Jerson on Twitter and at Connecticut Children's. Find Amber J Tresca at AboutIBD.com, Verywell, Facebook, Twitter, Pinterest, and Instagram. Credits: Mix and sound design is by Mac Cooney. Theme music, "IBD Dance Party,” is from ©Cooney Studio.
In episode 5 of an ongoing series of sharing sessions between a physician and patient, Anna Christina L. dela Cruz, MD, and Rhonda, who is living with chronic hepatitis B, discuss what to do when the decision to start treatment is not clear because of borderline ALT test results and HBV DNA levels. Their conversation highlights a need for patient education and shared decision-making.Presenter:Anna Christina L. dela Cruz, MDAssociate ProfessorDivision of Digestive Diseases and NutritionDepartment of Internal MedicineUniversity of KentuckyLexington, KentuckyContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program:https://bit.ly/3u196yK
Vegan and omnivorous diets promote equivalent muscle mass gain, study shows University of São Paulo (Brazil), May 19, 2021 Protein intake is more important than protein source if the goal is to gain muscle strength and mass. This is the key finding of a study that compared the effects of strength training in volunteers with a vegan or omnivorous diet, both with protein content considered adequate. In the study, which was conducted by researchers at the University of São Paulo (USP) in Brazil, 38 healthy young adults, half of whom were vegans and half omnivores, were monitored for 12 weeks. In addition to performing exercises to increase muscle strength and mass, the volunteers followed either a mixed diet with both animal and plant protein, or an entirely plant-based diet, both with the recommended protein content (1.6 gram of protein per kilogram of body weight per day). At the end of three months, there was no difference between vegans and omnivores in terms of muscle strength and mass increase. “Like any other protein in our organism, such as the proteins in our skin and hair cells, which die and are renewed, our muscles undergo synthesis and breakdown every day. Diet [protein intake] and exercise are the main protein balance regulators, favoring synthesis over breakdown,” said Hamilton Roschel, last author of the published study. Roschel is a University of São Paulo professor affiliated with both USP’s Sports and Physical Education School (EEEE) and Medical School (FM). He also heads the Applied Physiology and Nutrition Research Group jointly run by EEEE-USP and FM-USP. Protein sources are characterized primarily on the basis of essential amino acids, especially leukin, which plays a key role in anabolic stimulation of skeletal muscles. “Animal protein has more leukin than plant protein. Leukin is an essential amino acid in the anabolic stimulus signaling process. A plant-based diet is often thought to contain less leukin and hence trigger less anabolic stimulation, potentially affecting vegans’ capacity for muscle mass gain,” Roschel said. The study is published in Sports Medicine and resulted from the master’s research of Victoria Hevia-Larraín, with support from FAPESP. The study innovated by including a clinical analysis of the effects of protein source quality on muscle adaptation in vegans as compared with omnivores, since most research on the topic to date has focused on the acute anabolic response of muscles to protein intake under laboratory conditions and not on muscle mass as such. “Our findings show that there is no impairment of muscle mass gain for young adult vegans if they ingest the right amount of protein. In fact, the outcome of both diets was the same in this respect,” Roschel said. However, the researchers stress that, for the purposes of experimental control, protein intake was made the same in both diets by means of protein supplements. Omnivores and vegans were given milk serum protein isolate or soy protein respectively in accordance with individual dietary needs in order to attain the targeted protein intake. “In clinical practice, we know foods of animal origin generally have a higher protein content,” Roschel said. “Meat, milk and eggs contain more protein per gram than rice and beans, for example. In a clinical application with plant-based foods as the sole protein source, vegans would need to ingest a large amount of food to obtain the same amount of protein. In some specific cases, this could be a major challenge.” The protein source (mixed or plant-based diet) made no difference, provided each subject received an adequate amount of protein. “This result corroborates other data in the literature showing that a vegan diet can absolutely be complete if it is properly planned and executed,” Roschel said. “Previous studies suggest it can even be healthier than an omnivorous diet. For this to be the case, however, it requires appropriate nutritional counseling and education regarding people’s choices in restricting their intake to plant-based sources.” Another point noted by Roschel is that the subjects were healthy young adults, and the results might be different for older people or subjects with health problems. “Aging entails a phenomenon known as anabolic resistance, meaning a suboptimal anabolic response to the stimuli provided by diet and exercise compared with young people. Optimal response is possible in older people only if their protein intake is higher than that of the average healthy youngster. So we should be cautious about generalizing our findings for the entire population.” Yoga and breathing exercises aid children with ADHD to focus Ural Federal University, May 17, 2021 Yoga and breathing exercises have a positive effect on children with attention deficit hyperactivity disorder (ADHD). After special classes, children improve their attention, decrease hyperactivity, they do not get tired longer, they can engage in complex activities longer. This is the conclusion reached by psychologists at Ural Federal University who studied the effect of exercise on functions associated with voluntary regulation and control in 16 children with ADHD aged six to seven years. The results of the study are published in the journal Biological Psychiatry. "For children with ADHD, as a rule, the part of the brain that is responsible for the regulation of brain activity - the reticular formation - is deficient," said Sergey Kiselev, head of the Laboratory of Brain and Neurocognitive Development at UrFU, head of the study. "This leads to the fact that they often experience states of inadequate hyperactivity, increased distraction and exhaustion, and their functions of regulation and control suffer a second time. We used a special breathing exercise based on the development of diaphragmatic rhythmic deep breathing - belly breathing. Such breathing helps to better supply the brain with oxygen and helps the reticular formation to better cope with its role. When the reticular formation receives enough oxygen, it begins to better regulate the child's state of activity". In addition to breathing exercises, psychologists used body-oriented techniques, in particular, exercises with polar states "tension-relaxation". The trainings took place three times a week for two to three months (depending on the program). "Exercise has an immediate effect that appears immediately, but there is also a delayed effect. We found that exercise has a positive effect on regulation and control functions in children with ADHD and one year after the end of the exercise. This happens because the child's correct breathing is automated, it becomes a kind of assistant that allows better supply of oxygen to the brain, which, in turn, has a beneficial effect on the behavior and psyche of a child with ADHD," says Sergey Kiselev. This technique was developed by the Russian neuropsychologist Anna Semenovich as part of a neuropsychological correction technique. UrFU psychologists tested how well this approach helps children with ADHD. But the study is pilot, says Kiselev. It showed that these exercises have a positive effect. However, more work needs to be done, involving more children with ADHD. This will also take into account factors such as gender, age, severity of the disease, concomitant problems in children (speech, regulatory, etc.). Study findings suggest vitamin D deficiency may be associated with reduced arterial elasticity Guizhou Medical University (China), May 17, 2021 According to news reporting out of Guizhou, People’s Republic of China, research stated, “There is evidence that serum 25-hydroxyvitamin D [25-(OH) D] levels may be associated with cardiovascular disease and its risk factors. This study aimed to investigate the relationship between 25-(OH) D levels and blood pressure (BP), blood lipids, and arterial elasticity in middle-aged and elderly cadres in China.In this retrospective study, we included 401 civil servants and cadres aged >42 years who underwent medical examinations at Guiyang Municipal First People’s Hospital, China in 2018.” Our news journalists obtained a quote from the research from Guizhou Medical University, “The participants were assigned to deficiency ( 20 ng/mL), insufficiency (20-30 ng/mL), and sufficiency ( 30 ng/mL) groups according to 25-(OH) D levels in their blood. Demographics, brachial-ankle pulse wave velocity (baPWV), BP, ankle-brachial index (ABI), and blood lipids were compared among groups. The associations between 25-(OH) D and other parameters were evaluated using linear regression analysis.Median (range) 25-(OH) D levels in the deficiency (n = 162), insufficiency (n = 162), and sufficiency (n = 77) groups were 15.32 (2.93-19.88), 25.12 (20.07-29.91), and 33.91 (30.23-82.42) ng/mL, respectively. There were significant differences in systolic BP, pulse pressure, baPWV (left and right sides), ABI (left side), high-density lipoprotein-cholesterol, and triglycerides (TGs; all P< .05) among groups.” According to the news editors, the research concluded: “Multivariate linear regression revealed that TG, left baPWV, and right baPWV were significantly negatively correlated with 25-(OH) D levels (all P< .05).In this study, 25-(OH) D levels were found to be associated with TG, left baPWV, and right baPWV values. 25-(OH) D deficiency may be associated with reduced arterial elasticity.” Icing muscle injuries may delay recovery Kobe University and Chiba Institute of Technology (Japan), May 19, 2021 A study using a mouse model of eccentric contraction (*1) has revealed that icing injured muscles delays muscle regeneration. The discovery was made by a research group including Associate Professor ARAKAWA Takamitsu and then PhD. Student KAWASHIMA Masato from Kobe University's Graduate School of Health Sciences, and Chiba Institute of Technology's Associate Professor KAWANISHI Noriaki et al. In addition, the researchers illuminated that this phenomenon may be related to pro-inflammatory macrophages' (*2, 3, 4) ability to infiltrate damaged cells. This research raises questions as to whether or not severe muscle injuries (such as torn muscles) should be iced. These research results were published online as one of the Journal of Applied Physiology's Articles in Press on March 25, 2021. Main points The research results revealed that applying an ice pack to a severe muscle injury resulting from eccentric contraction may prolong the time it takes to heal. The cause of this phenomenon is that icing delays the arrival of pro-inflammatory macrophages, which are responsible for the phagocytosis (*5), or removal, of damaged tissue. Furthermore, this makes difficult for the macrophages to sufficiently infiltrate the damaged muscle cells. Research Background Skeletal muscle injuries encompass a range of damage to muscles; from a microcellular level to a severe level. These injuries include not only those that happen during sports or schools' physical education lessons but also external injuries that occur as a result of accidents and disasters. 'RICE treatment' is a common approach for skeletal muscle injuries, regardless of the extent of the injury. This acronym stands for Rest, Ice, Compression and Elevation and is often used in physical education, sports and even medicine. Ice is commonly applied regardless of the type of muscle injury, yet little is known about the long-term effects of icing. Ice is used to suppress inflammation, however, inflammation in response to tissue injury is one of the body's healing mechanisms. This has come to be understood as a vital response for tissue regeneration. In other words, suppressing inflammation with ice may also inhibit the body's attempt to repair itself. Experiments investigating the effect of icing muscles after injury have produced conflicting results. Some have reported that it delays muscle regeneration while others have stated that it doesn't inhibit this process. However, none of the research up until now has investigated the effects of icing using an injury model that mimics common sports injuries caused by muscle contraction. Using a mouse model of eccentric contraction injury, the current research team decided to observe the effects of post-injury icing. In this mouse model, injuries were induced to resemble severe torn muscles. Research Methodology and Results Eccentric contraction was induced by electrically stimulating the leg muscles of the mice and then exerting a stronger force during this stimulation to make the leg muscles move in the opposite direction. After this, the muscles were harvested. Icing was performed by placing polyurethane bags of ice on top of the skin over three 30 minute sessions per day, with each session being 2 hours apart. This was continued until two days after the injury. The icing was based on the usual clinically recommended method. The researchers investigated the regenerated skeletal muscle two weeks after injury, comparing the icing group with the non-icing group. A significantly higher percentage of smaller regenerated muscle fibers were found in cross-sections from the icing group, with a greater number of medium to large fibers in the non-icing group (Figure 1). In other words, this revealed that skeletal muscle regeneration may be delayed as a result of icing. Next, the researchers periodically took samples of muscle from the icing and non-icing groups of animals in order to investigate what was happening in the regeneration process up until this point. In the regeneration process, inflammatory cells gather at the site of the injury, remove the debris from the damaged muscle and then begin to build new muscle. However, the results revealed that it is harder for inflammatory cells to enter the injured muscle cells if ice is applied (Figure 2). Macrophages are typical of the inflammatory cells that enter the injured muscle. These consist of pro-inflammatory macrophages, which phagocyte damaged tissue thus causing inflammation, and anti-inflammatory macrophages (*6), which suppress the inflammatory reaction and promote repair. It is thought that pro-inflammatory macrophages change their characteristics, becoming anti-inflammatory. The results of this research team's experiments showed that icing delays the arrival of pro-inflammatory macrophages at the site of the injury (Figure 3). These results indicate the possibility that macrophages are unable to sufficiently phagocyte the damaged muscle when ice is applied after severe muscle injuries caused by eccentric contraction, consequently delaying the formation of new muscle cells. Comment from Associate Professor Arakawa In sports, the mantra of immediately applying ice to an injury is commonplace, regardless of the injury's severity. However, the mechanism that we illuminated through this research suggests that not icing a severe muscle injury may lead to faster recovery. The idea of immediately cooling any type of injury is also entrenched in schools' physical education classes. I hope that in the future, the alternative option of speeding up recovery by not cooling severe muscle injuries will become known. However, even though icing may disrupt the recovery process for severe muscle injuries, there is no denying the possibility that there are degrees of mild muscle injuries that can be iced. The next issue is to work out where to draw the line. We are now in the middle of investigating what effect icing has on slight muscle injuries. Next, we will continue to investigate how icing should be carried out according to the extent of the muscle injury. We aim to contribute guidelines that will enable people in sports and clinical rehabilitation to make accurate judgements about whether or not to ice an injury. Probiotics associated with fewer respiratory symptoms in overweight and older people Findings provide further evidence of relationship between the gut and lungs Imperial College London, May 14, 2021 Daily probiotic use was associated with fewer upper respiratory symptoms in overweight and older people, according to a study that suggests a potential role for probiotics in preventing respiratory infections. The study was selected for presentation at Digestive Disease Week® (DDW) 2021. "This is not necessarily the most intuitive idea, that putting bacteria into your gut might reduce your risk of respiratory infection," said Benjamin Mullish, MD, a lead researcher on the study and clinical lecturer in the Division of Digestive Diseases, Imperial College London, England, "but it's further evidence that the gut microbiome has a complex relationship with our various organ systems. It doesn't just affect how our gut works or how our liver works, it affects aspects of how our whole body works." Researchers re-analyzed detailed daily diaries of 220 patients who participated in an earlier double-blind placebo-controlled study on probiotics and weight loss. Reviewing the entries for common symptoms of upper respiratory infection, including cough, sore throat and wheezing, researchers found that participants who took probiotics during the six-month study had a 27 percent lower overall incidence of upper respiratory tract symptoms compared to the placebo group. The effect was largest among participants who were aged 45 years or older, as well as those with obesity. People with obesity are at higher risk for respiratory infections. Previous research has shown that probiotics reduce upper respiratory infections in healthy adults and children, but little data exists on this vulnerable population of older, overweight and people with obesity. "These findings add to growing interest in the gut-lung axis -- how the gut and the lungs communicate with each other," Dr. Mullish said. "It's not just the gut sending out signals that affect how the lungs work. It works in both directions. It adds to the story that changes in the gut microbiome can affect large aspects of our health." The researchers did not measure immune response, only respiratory symptoms. Future randomized clinical trials could help identify the mechanisms related to the reduction in respiratory symptoms and explore the possible impact of probiotics on the immune system, Dr. Mullish said. Fruit discovery could provide new treatments for obesity, type 2 diabetes and cardiovascular disease University of Warwick (UK), May 11, 2021 A combination of two compounds found in red grapes and oranges could be used to improve the health of people with diabetes, and reduce cases of obesity and heart disease. The find has been made by University of Warwick researchers who now hope that their discovery will be developed to provide a treatment for patients. Professor Thornalley who led research said: "This is an incredibly exciting development and could have a massive impact on our ability to treat these diseases. As well as helping to treat diabetes and heart disease it could defuse the obesity time bomb." The research 'Improved glycemic control and vascular function in overweight and obese subjects by glyoxalase 1 inducer formulation' has been published in the journal Diabetes, and received funding from the UK's innovation agency, Innovate UK. The project was a collaboration between the University of Warwick and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust. A team led by Paul Thornalley, Professor in Systems Biology at Warwick Medical School, studied two compounds found in fruits but not usually found together. The compounds are trans-resveratrol (tRES) - found in red grapes, and hesperetin (HESP) - found in oranges. When given jointly at pharmaceutical doses the compounds acted in tandem to decrease blood glucose, improve the action of insulin and improve thehealth of arteries. The compounds act by increasing a protein called glyoxalase 1 (Glo1) in the body which neutralises a damaging sugar-derived compound called methylglyoxal (MG). MG is a major contributor to the damaging effects of sugar. Increased MG accumulation with a high energy diet intake is a driver of insulin resistance leading to type 2 diabetes, and also damages blood vessels and impairs handling of cholesterol associated with increased risk of cardiovascular diseases. Blocking MG improved health in overweight and obese people and will likely help patients with diabetes and high risk of cardiovascular disease too. It has already been proven experimentally that blocking MG improves health impairment in obesity and type 1 and type 2 diabetes. Although the same compounds are found naturally in some fruits, the amounts and type required for health improvement cannot be obtained from increased fruit consumption. The compounds that increase Glo1 and are called a 'Glo1 inducer'. Pharmaceutical doses for patients with obesity, diabetes and high risk of heart disease could be given to patients in capsule form. Professor Thornalley increased Glo1 expression in cell culture. He then tested the formulation in a randomised, placebo-controlled crossover clinical trial. Thirty-two overweight and obese people within the 18-80 age range who had a BMI between 25-40 took part in the trial. They were given the supplement in capsule form once a day for eight weeks. They were asked to maintain their usual diet and their food intake was monitored via a dietary questionnaire and they were also asked not to alter their daily physical activity. Changes to their sugar levels were assessed by blood samples, artery health measured by artery wall flexibility and other assessments by analysis of blood markers. The team found that the highly overweight subjects who had BMIs of over 27.5 with treatment displayed increased Glo1 activity, decreased glucose levels, improved working of insulin, improved artery function and decreased blood vessel inflammation. There was no effect of placebo. Professor Thornalley said: "Obesity, type 2 diabetes and cardiovascular disease are at epidemic levels in Westernised countries. Glo1 deficiency has been identified as a driver of health problems in obesity, diabetes and cardiovascular disease." "Diabetic kidney disease will be the initial target to prove effective treatment for which we are currently seeking commercial investors and partners. Our new pharmaceutical is safe and expected to be an effective add-on treatment taken with current therapy. "The key steps to discovery were to focus on increasing Glo1 and then to combine tRES and HESP together in the formulation for effective treatment. "As exciting as our breakthrough is it is important to stress that physical activity, diet, other lifestyle factors and current treatments should be adhered to." Professor Martin O Weickert, Consultant in Diabetes and Endocrinology at UHCW NHS Trust, and co-applicant for the grant, said: "We were really excited to participate in this study with Warwick Medical School, as taking part in world-leading research makes a real difference to our patients both now and in the future. "As well as the positive effects for the UHCW patients who took part in the trial, we hope this study will lead to new treatments to help patients with diabetes and cardiovascular diseases all over the world." Prof. Thornalley and his team are now hoping manufacturers will want to explore the use of the compound as pharmaceutical products. Vitamin D supplementation associated with less time spent in ICU among critically ill patients Lishui People’s Hospital (China), May 18, 2021 According to news originating from Lishui, People’s Republic of China, research stated, “Vitamin D deficiency is a common scenario in critically ill patients and has been proven to be associated with poor outcomes. However, the effect of vitamin D supplementation for critically ill patients remains controversial.” Our news correspondents obtained a quote from the research from Lishui People’s Hospital: “Thus, we conducted a meta-analysis to evaluate the effect of vitamin D supplementation among critically ill patients. Electronic databases PubMed, Embase, Scopus, and the Cochrane Library were searched for eligible randomized controlled trials between 2000 and January 2021. The primary outcome was overall mortality, and the secondary ones were the length of intensive care unit stay, the length of hospital stay, as well as the duration of mechanical ventilation. Subgroup analyses were performed to explore the treatment effect by type of admission, route of administration, dose of supplemented vitamin D, and the degree of vitamin D deficiency. A total of 14 studies involving 2,324 patients were finally included. No effect on overall mortality was found between vitamin D supplementation and control group [odds ratio (OR), 0.73; 95% CI, 0.52-1.03; I2 = 28%]. The vitamin D supplementation reduced the length of intensive care unit stay [mean difference (MD), -2.25; 95% CI, -4.07 to -0.44, I2 = 71%] and duration of mechanical ventilation (MD, -3.47; 95% CI, -6.37 to -0.57, I2 = 88%). In the subgroup analyses, the vitamin D supplementation for surgical patients (OR, 0.67; 95% CI, 0.47-0.94; I2 = 0%) or through parenteral way (OR, 0.42; 95% CI, 0.22-0.82, I2 = 0%) was associated with reduced mortality.” According to the news reporters, the research concluded: “In critically ill patients, the supplementation of vitamin D has no effect on overall mortality compared to placebo but may decrease the length of intensive care unit stay and mechanical ventilation. Further trials are necessary to confirm our findings.”
We used to be told that women with IBD couldn’t have children. We were also told people with IBD shouldn’t have children. The truth is this: women with IBD get pregnant and have healthy pregnancies and babies. We have more evidence and guidance than ever before. Gastroenterologist Dr Jill Gaidos, Associate Professor of Medicine in the section of Digestive Diseases and the Director of Clinical Research for the Yale Inflammatory Bowel Diseases Program discusses the finer points of pregnancy and IBD. When to seek help for fertility, what medications should be continued in pregnancy, and the risk of passing on IBD to children. Concepts discussed in this episode: The PIANO Registry Conversations with Women in GI Updates on the Safety of Using Newer IBD Medications during Pregnancy Find Jill Gaidos, MD on Twitter and at Yale Health. Find Amber J Tresca at AboutIBD.com, Verywell, Facebook, Twitter, Pinterest, and Instagram. Credits: Mix and sound design is by Mac Cooney. Theme music, "IBD Dance Party,” is from ©Cooney Studio.
Acid reflux, stomach ulcers, SIBO, IBS, Leaky gut, colitis, C. diff., are some of the digestive diseases and disorders people all over the world suffer from every day. What are they? Is there a natural simple answer for them? Someone you know and love has one of them or will one day. We will offer some real safe and effective answers on how to treat them naturally.
Acid reflux, stomach ulcers, SIBO, IBS, Leaky gut, colitis, C. diff., are some of the digestive diseases and disorders people all over the world suffer from every day. What are they? Is there a natural simple answer for them? Someone you know and love has one of them or will one day. We will offer some real safe and effective answers on how to treat them naturally.
Acid reflux, stomach ulcers, SIBO, IBS, Leaky gut, colitis, C. diff., are some of the digestive diseases and disorders people all over the world suffer from every day. What are they? Is there a natural simple answer for them? Someone you know and love has one of them or will one day. We will offer some real safe and effective answers on how to treat them naturally.
Iago Rodríguez-Lago, trainee editor, talks to Stephan Miehlke (Center for Digestive Diseases, Hamburg, Germany) about the recent guidelines from the European Microscopic Colitis Group published in UEG Journal.
This Podcast is for educational purposes only not intended to treat cure diagnose or prevent sickness illness disease or mental health issues if you are making any lifestyle changes to your health and wellness routine for yourself and family consult with your medical doctor first. Topic: Misuse of Herbs References BJORNDAL, C. (2015). Bulimia. Naturopathic Doctor News &Review, 11(3). 20-21 Kashyap, P (7 October 2009). "Psychological treatments for bulimia nervosa and binging". The Cochrane Database of Systematic Reviews(4) What Are Major Eating Disorders? (2014). Nutrition Health Review: The Consumer’s Medical Journal, (111), 2 Moriarty, K. J.; Silk, D. B. (1988). "Laxative Abuse". Digestive Diseases. 6 (1) Smink, F. R. E., van Hoeken, D., & Hoek, H. W. (2012). Epidemiology of Eating Disorders: Incidence, Prevalence and Mortality Rates. Current Psychiatry Reports, 14(4), 406–414. #holistmedicine #alternativehealtj --- Send in a voice message: https://anchor.fm/rdlc/message Support this podcast: https://anchor.fm/rdlc/support
John Allen, M.D is the Chief Clinical Officer of the University of Michigan Medical Group and is also on the board of Allina Health. In 2019, AGA presented its highest honor, the Julius Friedenwald Medal for his contributions to gastroenterology. Previously, he was the chief of Digestive Diseases at Yale and helped build Minnesota Gastroenterology (now MNGI), one of the largest GI practices in the country. This interview is so insightful that it'll help you make several business and personal decisions for the long haul. Here's specifically what you'll take away: 1) What does it take lead calmly and steadily through a crisis? Especially a large health system 2) Planning for another pandemic (or another wave) should it occur 3) Fundamental shifts in GI and US healthcare economics that we are not yet recognizing 4) Weighing pros and cons of private equity 5) Future of gastroenterology - technology, consolidation, ethics and morals
Guest Name and Bio: Emeran Mayer, MD Emeran A Mayer is a Gastroenterologist, Neuroscientist and Professor in the Departments of Medicine and Psychiatry in the Division of Digestive Diseases at the David Geffen School of Medicine at UCLA. He is the Executive Director of the G. Oppenheimer Center for Neurobiology of Stress and Resilience at UCLA, and co-director of the CURE: Digestive Diseases Research Center. As one of the pioneers and leading researchers in the role of mind-brain-body interactions in health and chronic disease, his scientific contributions to U.S. national and international communities in the broad area of basic and translational enteric neurobiology with wide-ranging applications in clinical GI diseases and disorders is unparalleled. He has published more than 350 scientific papers, and co edited 3 books. He has published the bestselling book The Mind Gut Connection, and is currently working on a second book to be published in early 2021. He is the recipient of the 2016 David McLean award from the American Psychosomatic Society and the 2017 Ismar Boas Medal from the German Society of Gastroenterology and Metabolic Disease. His research interest is focused on the role of brain gut microbiome interactions in human diseases, including Alzheimer’s and Parkinson’s disease, autism spectrum disorders, obesity and inflammatory bowel disease. Mayer has a longstanding interest in ancient healing traditions and affords them a level of respect rarely found in Western Medicine. He has been involved in documentary film productions about the Yanomami people in the Orinoco region of Venezuela, and the Asmat people in Irian Jaya. He has recently co produced the award winning documentary “In Search of Balance” and is working on a new documentary “Interconnected Planet”. He is a strong believer in Buddhist philosophy, was a member of the UCLA Zen Center for several years, and got married in a Tibetan monastery by Choekyi NyimaRinpoche in Kathmandu. He regularly pursues meditative practices. Dr. Mayer has been interviewed on National Public Radio, PBS and by many national and international media outlets including the Los AngelesTimes, Atlantic magazine and Stern and Spiegel Online. He has spoken at UCLA TEDx on the Mysterious Origins of Gut Feelings in 2015, and his bestsellingbook The Mind Gut Connection was published by Harper&Collins in July of 2016 and has been translated into twelve languages. What you will learn from this episode: 1) What the best diet for the gut microbiome is 2) How to optimize the mind-gut connection 3) What impacts food cravings and the desire to eat comfort foods 4) Which microbes are the most important to us 5) What can cause certain good bacteria to turn into bad or harmful bacteria in the gut microbiome How to learn more about our guest: emeranmayer.com uclacns.org microbiome.ucla.edu Facebook: @emeranamayer IG: @emeranamayer Linkedin: @emeranamayer Please enjoy, share, rate and review our podcast and help us bring the message about precision health care to the world!
Kids with chronic illness face special issues when going back to school because they’re at risk of their accommodations becoming eroded. In particular, children who live with Crohn’s disease or ulcerative colitis, might be in danger of not being granted appropriate bathroom access. I speak with Dr Brad Jerson, a Pediatric Psychologist in the Division of Digestive Diseases, Hepatology, and Nutrition at Connecticut Children’s and an Assistant Professor of Pediatrics at the University of Connecticut School of Medicine. We discuss the worrying behaviors that parents should watch out for in their kids and how we can help kids who feel scared to go back to school. Episode transcript: https://bit.ly/AIBD78 Concepts discussed in this episode: How to Practice Active Listening How Is Your Child Coping With COVID-19? Here’s What to Look For Managing Family Stress During COVID-19 Template Section 504 Plan for Children with Inflammatory Bowel Disease IBD Patient Advocacy Organizations Connecting to Cure Crohn's and Colitis Crohn's and Colitis Australia Crohn’s and Colitis Canada Crohn's and Colitis New Zealand Crohn’s and Colitis Foundation The European Federation of Crohn's & Ulcerative Colitis Associations Girls With Guts IBDMoms (Amber is a co-founder) IBD Apps Gali Health (Affiliate Link) The Mighty Healthline IBD (Includes Podcasts Hosted By Amber) Find Dr Brad Jerson on Twitter and at Connecticut Children’s. Find Amber J Tresca at AboutIBD.com, Verywell, Facebook, Twitter, Pinterest, and Instagram. Credits: Mix and sound design is by Mac Cooney. Theme music, "IBD Dance Party,” is from ©Cooney Studio.
Back to school will be quite different for families across the United States and the world this year. There aren’t many answers to be had to our questions, yet we must make decisions with the best information that we have at this time. I speak with Dr Brad Jerson, a Pediatric Psychologist in the Division of Digestive Diseases, Hepatology, and Nutrition at Connecticut Children’s and an Assistant Professor of Pediatrics at the University of Connecticut School of Medicine about how we can prepare our kids, and ourselves, for the school year. We discuss the behaviors we can model for our children, how we can talk to young kids about mask wearing, and how to engage kids of all ages in conversation about their fears and anxieties during this time. Concepts discussed in this episode: A Checklist to Help Parents Decide: Send Kids Back to School or Keep Them Home During COVID-19? Is It Safe to Send Your Child Back to School During COVID-19? Advice From Connecticut Children’s Physician-in-Chief Ask a Pediatrician: Is It a Good Idea for My Child With Asthma to Go Back to School or Day Care During COVID-19? 7 Ways to Introduce Your Child to Wearing a Mask Coronavirus and IBD Reporting Database Find Dr Brad Jerson on Twitter and at Connecticut Children’s. Find Amber J Tresca at AboutIBD.com, Verywell, Facebook, Twitter, Pinterest, and Instagram. Credits: Mix and sound design is by Mac Cooney. Theme music, "IBD Dance Party,” is from ©Cooney Studio.
Podcast: Colon Cancer: Updates in Screening Guidelines Evaluation and Credit: https://www.surveymonkey.com/r/MedChat15 Target Audience This activity is targeted toward internal medicine, family medicine and primary care specialties that provide primary care to patients with seizures and/or epilepsy. Statement of Need Colorectal cancer (CRC) is one of the top cancer-related deaths in the US, yet it is has been documented that implementing the latest screening protocols can reduce the incidence and mortality of CRC. In that most colon tumors develop in stages, screening can detect early-stage precancerous polyps before they become cancerous. Therefore it is critical for physicians to understand the latest screening protocols and recommendations for CRC. Objectives At the conclusion of this offering, the participant will be able to: List the risk factors for colorectal cancer. Understand the stages of colorectal disease development. Discuss the latest screening guidelines for colorectal cancer. Describe the different colorectal screening / diagnostic tools and indications. Moderator Ryan Nazar, M.D. Clinical Effectiveness Director, Quality Management Norton Medical Group Speakers Ryan Jones, M.D. Colon and Rectal Surgery Norton Surgical Specialists Michelle Julien, M.D. Colon and Rectal Surgery Norton Surgical Specialists Moderator, Speaker and Planner Disclosures The moderator, speaker and planners for this activity have no potential or actual conflicts of interest to disclose. Commercial Support There was no commercial support for this activity. Physician Credits American Medical Association Accreditation Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. Designation Norton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse Credits Kentucky Board of Nursing (KBN) Approved Provider: Norton Healthcare, provider number 4-0002-12-20-198. The program has been approved by Norton Healthcare for 0.9 contact hours which expires 12/31/2020. KBN approval of a continuing education provider does not constitute endorsement of program content. Nursing participants must attest to the number of hours of attendance and complete the evaluation to receive contact hours. For more information related to nursing credits, contact Sally Sturgeon DNP, RN, SANE-A, AFN-BC at (502) 446-5889 or sally.sturgeon@nortonhealthcare.org. Date of Original Release |June 2020 Course Termination Date | December 2021 Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org Resources for Additional Study Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. https://www.ncbi.nlm.nih.gov/pubmed/30875085 Chapkin, Robert, et. al. Diet and Gut Microbes Act Cooridnately to Enhance Programmed Cell Death and Reduce Colorectal Cancer Risk. Digestive Diseases and Sciences (2020) 65: 840 – 851. Issa, Iyad, and Noureddine, Malak. Colorectal cancer screening: An updated review of the available options. World Journal of Gastroenterology; 2017 July 28: 23(28): 5086 – 5096. Primary tumor location and survival in colorectal cancer: A retrospective cohort study. https://www.ncbi.nlm.nih.gov/pubmed/32368319 Stoffel, Elena, and Murphy Caitlin. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. Gastroenterology, 2020 (158:341 – 353. Primary tumor location and survival in colorectal cancer: A retrospective cohort study. https://www.ncbi.nlm.nih.gov/pubmed/32368319 Xyu, M.D., Zhaomin, et. al. Treatments for Stage IV Colon Cancer and Overall Survival. Journal of Surgical Research, October 2019 (242) 47 – 56.
I've been getting an overwhelming amount of questions about COVID-19 and probiotics, IBD, IBS, and immunity. I wanted to take some time to answer these in a simple way for our listeners. The information was recorded March 19th and therefore, statistics and recommendations may change - always check with your doctor. We cover: What is COVID-19? Why is COVID-19 a concern? Who is most at risk? GI Symptoms and COVID-19 - should I be concerned? "I have IBD and am worried about getting COVID - what do I need to know?" Your gut and your immune system How nutrition plays a role in your immune system Probiotics & COVID-19 How to take care of your health during this challenging time Citations Gao, Q. Y., Chen, Y. X., & Fang, J. Y. (2020). 2019 novel coronavirus infection and gastrointestinal tract. Journal of Digestive Diseases. Mao, R., Liang, J., Shen, J., Ghosh, S., Zhu, L. R., Yang, H., ... & Chen, M. H. (2020). Implications of COVID-19 for patients with pre-existing digestive diseases. The Lancet Gastroenterology & Hepatology. Gu, J., Han, B., & Wang, J. (2020). COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. Xiao, F., Tang, M., Zheng, X., Li, C., He, J., Hong, Z., ... & Lai, R. (2020). Evidence for gastrointestinal infection of SARS-CoV-2. medRxiv. Resources for IBD Healthcare Professionals: 2019 Novel Coronavirus (COVID-19). (2020, March 17). Retrieved March 18, 2020, from https://www.crohnscolitisfoundation.org/coronavirus/professional-resources Mizumoto K, Chowell G. Estimating risk for death from 2019 novel coronavirus disease, China, January–February 2020. Emerg Infect Dis. 2020 Jun [Retreived March 18, 2020]. https://doi.org/10.3201/eid2606.200233
Dr. Ali Rezaie is a gastroenterologist and epidemiologist out of Los Angeles California who practices in and researches irritable bowel syndrome, motility disorders in patients with inflammatory bowel disease and does population-based data analysis. He runs the Rezaie Lab out of Cedars Sinai and has published over 60 research articles in peer-reviewed journals including Gastroenterology, American Journal of Gastroenterology, Digestive Diseases and Sciences and Canadian Journal of Gastroenterology. His works have been cited more than 4,000 times by other scientific journals. Dr. Rezaie serves as the associate editor of the Journal of Digestive Disease and Sciences. He also trained in my home province in both Calgary and Edmonton where I’ve worked – so I feel like we’re connected in that way! Dr. Ali Rezaie and I discuss: What is SIBO? The most common causes of SIBO Phases of digestion What tests are evidence-based for SIBO? What are the benefits and limitations of small bowel cultures versus hydrogen and methane breath testing How is SIBO diagnosed Where science is going to diagnose SIBO Is stool testing an appropriate test for SIBO? How do you respond when someone says ‘SIBO isn’t a real diagnosis’ What are some current challenges with SIBO diagnosis and what research is needed? Why we need biomarkers for subtypes of IBS Current therapies to treat SIBO How should someone struggling with digestive issues who maybe think they have SIBO get started Stay up to date on his work on Twitter @AliRezaieMD or through The Rezaie Research Lab.
Thank you for joining us on the most important episode we've published to date, and perhaps will be the most important episode we will publish - for more reasons than we could possibly articulate here in written text. In this episode, we discuss the inescapably difficult but exceedingly important matter of quality versus quantity life - when given a terminal diagnosis. It is impossible to convey our saddened we are that a dear friend to this show, Dr. Karen Rees-Milton (who joined us on episode 27), is bravely surviving a terminal diagnosis. As a true reflection of her character, commitment, and passion for life, Karen wishes to broach with us just how important it is for communication between doctors and patients about the end of life. We are also so grateful to be joined by Dr. Sarah McLean, an Assistant Professor of Physiology & Pharmacology and Anatomy & Cell Biology at Western University's Schulich School of Medicine & Dentistry. Like Karen, Sarah is an expert in cancer research - and she too has directly experienced the pains of being a centre for communication for and between her brothers, doctors, and her dear father, who she lost very quickly to cancer in the summer of 2019. Karen and Sarah are experts in cancer research, and their direct experiences with cancer make for a particularly important conversation. As you will see, doctors do not always communicate quickly or efficiently about terminal diagnoses. The very human impulse to make people happy in desperate situations often creates moral ambiguity that distracts from the hard but important conversation about whether or not often debilitating treatments are worth one's precious time. We hope that you will use this episode as a guide to help you when faced with these difficult matters, as we all will inevitably deal with them - one way, or another. As mentioned in the episode, please visit the London Regional Cancer Program, the Zane Cohen Centre for Digestive Diseases, Kingston General Hospital's Endoscopy Unit, and Jayne Dill's (RN) New Before You Go - a wonderful woman and tremendous resource for helping us navigate matters of value, wishes, and communication when dealing with the end of life. Follow your hosts: @Derekcrim | @whatsthatdata | @wtncast Dr. Sarah McLean can be followed on Twitter @drsarahmclean Email us Subscribe for updates Follow us on Apple Music and Spotify
#130 Mark Pimentel, is Professor of Medicine at Geffen School of Medicine and Cedars-Sinai Medical Center in Los Angeles. He is also the Executive Director of the Medically Associated Science and Technology (MAST) Program at Cedars-Sinai Medical Center. Dr. Pimentel completed 3 years of an undergraduate degree in honors microbiology and biochemistry. This was followed by his medical degree, and his BSc (Med) from the University of Manitoba Health Sciences Center, where he also completed a residency in internal medicine. His medical training includes a fellowship in gastroenterology at the UCLA Affiliated Training Program. Active in research, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical studies in such areas as IBS, and the relationship between gut flora composition and human disease. His work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others. Dr. Pimentel is a diplomate of the American Board of Internal Medicine (Gastroenterology) and a fellow of the Royal College of Physicians and Surgeons of Canada. In this episode we cover The link between autoimmunity and SIBO The IBS smart test Hydrogen sulphide SIBO including assessment, treatment Prokinetics - how long, who for Why excess weight may be common in methane dominant SIBO Is the lactulose or glucose breath test better for determining SIBO And so much more
How and why Parkinson’s disease (PD) starts and progresses is still not exactly known, but active research points to genetics and environment, among other factors. The environment is both external and internal – external in terms of what people encounter outside their bodies and internal in terms of what is inside their bodies. Researchers studying a variety of diseases have learned the importance of the microbiome in health and disease. The microbiome consists of all those bacteria, fungi, and viruses that occupy niches on and inside of people, such as on the skin, in the nose and mouth, and in the gut. These organisms can have far reaching effects in the body, distant from their own locations. Some of these interactions can affect the brain. Ali Keshavarzian, MD, Chief of the Division of Digestive Diseases and Nutrition at Rush University in Chicago has been studying the role of the gut microbiome and its relation to inflammation, such as in inflammatory bowel disease, in addition to more distant sites including in the brain. His research includes the role of the gut microbiome as a contributing factor to the development and progression of PD as well as the potential to manipulate it to help manage the disease. He conducts both basic science research using animal models and clinical research with people with PD.
If you or someone you know is dealing with a digestive disease, you'll want to learn and research everything about oxygenating to restore balance, water, nutrition, sleep, and more. Learn more with Google searches or uofhealth.webs.com. Brought to you by W-Home Solutions and Panasonic solar panels.
In this episode we explore gluten, Celiac disease, and the evidence behind utilizing gluten-free diets as a weight loss tool. Articles/references: Aziz, I., Dwivedi, K., & Sanders, D. S. (2016). From coeliac disease to noncoeliac gluten sensitivity; should everyone be gluten free? Current Opinion in Gastroenterology,32(2), 120-127. doi:10.1097/mog.0000000000000248 NCGS and the benefits of a GFD are reported amongst patients with irritable bowel syndrome, inflammatory bowel disease, and non intestinal disorders such as neuropsychiatric diseases and fibromyalgia. However, no reliable biomarkers currently exist to diagnose NCGS and hence confirmatory testing can only be performed using double-blind placebo-controlled gluten-based challenges. Unfortunately, such tests are not available in routine clinical practice. Furthermore, recent novel studies have highlighted the role of other gluten-based components in contributing to the symptoms of self-reported NCGS. These include fermentable oligo, di, mono-saccharides and polyols, amylase trypsin inhibitors, and wheat germ agglutinins. Therefore, NCGS is now seen as a spectrum encompassing several biological responses and terms such as 'non coeliac wheat sensitivity' have been suggested as a wider label to define the condition. Jamieson, J. A., Weir, M., & Gougeon, L. (2018). Canadian packaged gluten-free foods are less nutritious than their regular gluten-containing counterparts. PeerJ,6. doi:10.7717/peerj.5875 And in Canada - Jamieson study: GF staples (cereals, breads, flours, pastas) contained 1.3 times more fat and less iron (by 55%), folate (by 44%) and protein (by 36%), than GC counterparts (P < 0.0001). On average, GF pastas had only 37% of the fibre in GC pastas (P < 0.0001). Notably, GF and GC flours were equivalent in nutrient content. Despite GF and GC flours having similar nutritional content, the vast majority of the processed GF foods fell short in key nutrients. Missbach, B., Schwingshackl, L., Billmann, A., Mystek, A., Hickelsberger, M., Bauer, G., & König, J. (2015). Gluten-free food database: The nutritional quality and cost of packaged gluten-free foods. PeerJ,3. doi:10.7717/peerj.1337 Missbach: Similar GF discretionary food database → less fiber, less protein overall, and ranging from 206% to 267% higher in cost than their gluten-containing ( glutenous) counterparts. Taetzsch, A., Das, S., Brown, C., Krauss, A., Silver, R., & Roberts, S. (2018). Are Gluten-Free Diets More Nutritious? An Evaluation of Self-Selected and Recommended Gluten-Free and Gluten-Containing Dietary Patterns. Nutrients,10(12), 1881. doi:10.3390/nu10121881 Theethira, T. G., & Dennis, M. (2015). Celiac Disease and the Gluten-Free Diet: Consequences and Recommendations for Improvement. Digestive Diseases,33(2), 175-182. doi:10.1159/000369504 Wu, J. H., Neal, B., Trevena, H., Crino, M., Stuart-Smith, W., Faulkner-Hogg, K., . . . Dunford, E. (2015). Are gluten-free foods healthier than non-gluten-free foods? An evaluation of supermarket products in Australia. British Journal of Nutrition,114(03), 448-454. doi:10.1017/s0007114515002056 Wu study: Australian supermarket health index comparison between foods labelled gf and those containing wheat or wheat product/rye or barley were equivocal and overall contained less protein http://freakonomics.com/podcast/demonization-gluten/ Notes from AND Evidence Analysis Library
Much existing propaganda claims that African Americans do not suffer from celiac disease. Even the Gluten Free RN was surprised to find out that her adopted daughter had a genetic predisposition to the disease back in 2006, as research available at the time regarded the HLA-DQ2 and HLA-DQ8 genes to be primarily Caucasian traits. And until we take steps to conduct a mass screening, we simply don’t know how common celiac disease is among people of African descent. Today, the Gluten Free RN is exploring celiac disease in the African American population. She covers a 2006 study out of Columbia University that assessed African American celiac patients, discussing the variety of ways the subjects presented with celiac disease and the potential reasons for their poor compliance with the prescribed gluten-free diet. Nadine also considers the prevalence of celiac disease on the continent of Africa, explaining why she believes the number of celiac patients will explode with the population’s growing exposure to wheat. Listen in for the Gluten Free RN’s insight on other health issues that may point to undiagnosed celiac disease and learn how we can prevent celiac disease among the African American population with access to testing, social support and gluten-free food! What’s Discussed: The 2006 Columbia University study of celiac disease in African Americans Identified nine patients with biopsy-proven celiac disease Presented with diarrhea, iron deficiency anemia and autoimmune disorders Why patients in the Columbia study demonstrated poor dietary compliance Expense, availability and palatability of gluten-free food Lack of symptoms at diagnosis, inaccurate dietary information Nadine’s prediction around the number of celiac patients in Africa Increasing exposure to wheat will cause explosion The statistics regarding the mortality burden of celiac disease Science Daily reported estimates of 42K child deaths every year in 2011 Majority from Africa and Asia The overlap between diabetes and celiac disease Every type 1 diabetic is HLA-DQ2/8 gene carrier The health issues that may indicate undiagnosed celiac disease Type 1 diabetes, cardiac issues, stroke and heart attack Obesity (stems from lack of nutrient absorption) How to prevent celiac disease among the African American population Access to testing, social support and gluten-free food Resources: Celiac Disease and How Gluten Affects Your Skin EP011 ‘Your Skin on Gluten’ on YouTube ‘Celiac Disease in African-Americans’ in Digestive Diseases and Sciences ‘First Global Estimates of Coeliac Disease and Its Mortality Burden’ in Science Daily Neurological Disorders Associated with Celiac Disease EP012 ‘Celiac Disease in the Developing Countries: A New and Challenging Public Health Problem’ in the World Journal of Gastroenterology ‘Systematic Review: Worldwide Variation in the Frequency of Coeliac Disease and Changes Over Time’ in Alimentary Pharmacology and Therapeutics ‘HLA Typing and Celiac Disease in Moroccans’ in Medical Sciences ‘A Historical Assessment of Sources and Uses of Wheat Varietal Innovations in South Africa’ in the South African Journal of Science University of Chicago: Celiac Disease Facts and Figures ‘Adult Coeliac Disease in South Africa: An Analysis of 20 Cases Emphasizing Atypical Presentations’ in the South African Medical Journal ‘Epidemiological and Clinical Features in Immigrant Children with Coeliac Disease: An Italian Multicentre Study’ in Digestive and Liver Disease ‘Prevalence of Positive Coeliac Serology in a Cohort of South African Children with Type 1 Diabetes Mellitus’ in the South African Journal of Child Health ESPGHAN Goes Africa Course Connect with Nadine: Instagram Facebook Contact via Email ‘Your Skin on Gluten’ on YouTube Melodies of the Danube Gluten-Free Cruise with Nadine Books by Nadine: Dough Nation: A Nurse's Memoir of Celiac Disease from Missed Diagnosis to Food and Heal
It goes without saying that anyone who serves in the military needs to be healthy and strong—and that military leaders have an obligation to keep enlisted servicemen and women as safe and healthy as possible. So, it makes sense that people with food allergies (including celiac patients) are disqualified from military service, but it is less clear why celiac testing is not a part of the medical exam to qualify for enlistment. Today, the Gluten Free RN addresses the issue of celiac disease in the military. She explains the challenges of preparing gluten-free food in a mess hall setting and describes the consequences for an active duty soldier who is found to have celiac disease. Nadine shares a research study exploring celiac trends among active duty military as well as a case study around veterans and celiac disease. Listen in for insight on what’s behind the increased prevalence of celiac disease among military personnel and the confirmed association between celiac disease and other complex health issues. What’s Discussed: Why celiac patients are disqualified from enlisting in any branch of service Unable to provide safe food What happens to military personnel who are found to have celiac disease Will receive medical discharge The US military policy around food allergies and intolerances No accommodations made Countries that allow celiac patients to serve Israel, Finland and Scandinavia The Mayo Clinic study of celiac trends among active duty military Healthy worker population with medical diagnostic coding Incidence of celiac disease increased five-fold from 1999-2008 Combination of increased suspicion and environmental factors The challenge of preparing gluten-free food in a military setting High risk of cross-contamination A case study involving military veterans and celiac disease Confirmed association between CD and other complex issues The benefits of a gluten-free diet Preventative for autoimmune disorders, nutritional deficiencies and cancer Nadine’s argument for celiac testing prior to enlistment Obligation to safety of servicemen/women Resources: Military Standards of Medical Fitness ‘The Incidence and Risk of Celiac Disease in a Healthy US Adult Population’ in the American Journal of Gastroenterology ‘Celiac Sprue Among US Military Veterans: Associated Disorders and Clinical Manifestations’ in Digestive Diseases and Sciences ‘Gluten-Free Soldier in Afghanistan’ in Gluten-Free Living ‘Medical Mix-Up Sidelines Army Sergeant’s Career’ in Military Times Celiac Disease-Related Veterans Affairs Case Connect with Nadine: Instagram Facebook Contact via Email ‘Your Skin on Gluten’ on YouTube Melodies of the Danube Gluten-Free Cruise with Nadine Books by Nadine: Dough Nation: A Nurse's Memoir of Celiac Disease from Missed Diagnosis to Food and Health Activism
Nadine spent 17 years working as a nurse in the ER. She holds a membership in the Emergency Nurses Association, as well as a Certified Emergency Nurse certification. During the course of her career, Nadine obtained ACLS, PALS, NALS, ENPC and TNCC certifications, honing her skills in advanced cardiac life support, neonatal advanced life support, pediatric advanced life support, and trauma. Despite this impressive background and experience, she had never been educated about celiac disease, and didn’t know what to look for until she was diagnosed herself. Nurses are in a unique position to recognize potential celiac patients and act appropriately. Though most nurses don’t have the authority to diagnose, they do have an obligation to act as patient advocates. Because celiac disease is the most underdiagnosed and misdiagnosed autoimmune disease in the world, it is important that nurses get educated about the fundamentals of celiac disease, the wide array of symptoms an undiagnosed patient may present, and how to keep celiac patients safe in and out of the hospital. Today on the podcast, the Gluten Free RN addresses nurses, explaining how celiac disease damages the GI tract, the consequences of a ravaged immune system, and the neurological nature of the disease. She also reviews the genes that indicate a predisposition to celiac disease, the best available tests for gluten sensitivity, and the need for a worldwide mass screening. This is a must-listen for medical professionals, offering an overview of the most current celiac studies and an explanation of how to approach doing research on your own. Celiac disease is on the rise and it doesn’t discriminate, so it is crucial that the nursing community get educated – STAT. What’s Discussed: Why nurses need to employ a high index of suspicion regarding celiac disease Most undiagnosed and misdiagnosed autoimmune disease in world The lack of training around celiac disease in the medical community Nadine was nurse for 17 years Didn’t know symptoms of celiac disease Diagnosed ‘by accident’ The celiac symptoms Nadine thought to be ‘normal’ Canker sores Intermittent constipation, diarrhea Eczema on hands Difficult time gaining weight Whole family had gas What nurses need to know about celiac disease What it is, what it entails Symptoms may present with How to keep patients safe (in and out of hospital) How to request testing How to interpret lab results How long it takes to receive celiac diagnosis in US 9-15 years The restrictions of being a nurse Can’t diagnose (can recognize, treat appropriately) Can’t perform surgery Can’t prescribe meds, take patient off medication Nadine’s experience leading up to her celiac diagnosis Nadine’s celiac diagnosis Dermatologist diagnosed Blood test, skin biopsy negative HLA-DQ2.5 gene carrier (super-celiac category) Why a negative blood test, skin biopsy doesn’t rule out celiac disease Nadine’s current health Why Nadine stopped working as an ER nurse Celiac diagnosis was life-changing Started own businesses RN On Call, Inc The Gluten Free RN Celiac Nurse Consulting The increased prevalence of mortality in undiagnosed celiac patients Undiagnosed celiac disease associated with 4-fold increased risk of death (45 years of follow-up) Prevalence of undiagnosed celiac disease has increased dramatically in US over last 50 years The grains that contain gluten Wheat Barley Rye Oats (cross-contamination) The products that may contain gluten Medication Food Personal care products The search terms to use when doing celiac research Gluten-related disorders Both spellings (celiac, coeliac) Why celiac disease is primarily a neurological disorder Involves enteric nervous system (in intestines) Vagus nerve (superhighway of information from intestines to brain) Why celiac disease is not an allergy Allergy is IgE-mediated antibody response Celiac tends to be IgA, IgG-mediated antibody responses The genes that indicate a predisposition to celiac disease HLA-DQ2 HLA-DQ8 Why Nadine advocates for a world-wide mass celiac screening The relationship between celiac disease and infertility People with infertility issues, difficulty maintaining pregnancy should be tested The chronic nature of celiac disease Never goes away Gluten is neurotoxin Must be 100% gluten-free for life How gluten exposure presents for Nadine Blisters in mouth within 10 minutes How gluten can cause damage along entire length of GI tract 28 to 32 feet in length Person-to-person variability How damage to GI tract presents Canker sores Difficulty swallowing, dysphasia GERD Eosinophilic esophagitis Gas, bloating Diarrhea constipation Crohn’s disease Atypical diseases Idiopathic diseases Ulcerative colitis Diverticulitis Diverticulosis Rectal cancer Bowel cancer Hemorrhoids How constipation can be a neurological issue Gluten as neurotoxin can paralyze nervous system, intestines Stool cannot get pushed through Can result in colon cancer, megacolon Disorders that may be caused by undiagnosed celiac disease Diabetes Heart problems Sudden cardiac deaths Strokes Bowel, rectal cancer (recent increase in young people) Why a biopsy is no longer considered the gold standard of celiac testing Positive anti-tissue transglutaminase and positive EMA indicates damage to intestines Endoscopist should take six to 15 samples in duodenum, jejunum (damage can be patchy) The stages of intestinal damage caused by celiac disease Marsh 1 – microvilli destroyed Marsh 2, 3 – villi themselves fall over, blunt or atrophy Marsh 4 – looks like hot, inflamed sponge and immune system compromised The consequences of a damaged immune system Hypo-responsive (doesn’t respond) Hyper-responsive (reacts to everything) The importance of including a total IgA and IgG in the celiac antibody panel Ensure patient is not IgA deficient How the US has gone backwards in the last 70 years Times article from 1950 declares ‘cures certain in 90% of cases’ and ‘deaths rare’ Celiac disease has gone unrecognized since then The testing for celiac disease Celiac antibody test (baseline) Small intestinal biopsy Nutritional panel (D3, B6, B12, magnesium RBC, zinc, ferritin) Follow-up to track healing, ability to absorb nutrients The difficulty with the celiac antibody test 70% false negative The best available celiac testing EnteroLab Gluten Sensitivity Stool Test Cyrex Laboratories Array 3 Factors that might interfere with accurate celiac testing IgA deficiency Benicar (blood pressure med) known to cause villous atrophy in absence of celiac disease Lab-to-lab variability Only tests for anti-tissue transglutaminase 2 How to carry out a clinical trial for celiac disease or gluten sensitivity Adopt gluten-, dairy-free diet for at least three months It takes six months to a year for intestines to heal Recommended for patients with genetic predisposition, regardless of negative blood test The Paleo diet Nadine suggests for celiac and gluten-sensitive patients Whole food Meat, fish and eggs Nuts and seeds Fruits and vegetables The findings of a celiac study published in the Journal of Insurance Medicine Atypical, non-diarrheal presentations now most frequent Celiac disease is grossly underdiagnosed in US Average delay in diagnosis for adult patients ranges from four to 11 years Diagnosis and treatment with gluten-free diet leads to improved quality of life Medical costs in celiac cohort were 31% lower over three-year period Why celiac disease should be on every primary care physician’s differential diagnosis The rise of celiac disease 1:501 in 1974 1:219 in 1989 1:100 is current estimate Doubles every 15 years (according to Mayo Clinic) Why Celiac disease is a worldwide issue Affects every ethnicity Frequency of tTGA in Mexico City study was 1:37 Increasing diagnoses in North Africa, Middle East and Northern India How celiac disease can lead to obesity Patient cannot absorb nutrients (malnourished) Body responds by storing fat for cheap energy How the risk of cancer increases exponentially in undiagnosed celiac patients Why nurses must be patient advocates Nadine’s advice around research and celiac disease for nurses Not taught in nursing programs Do your own research to keep up with current info Resources: Snarky Nurses on Instagram National Nurses in Business Association “Increased Prevalence and Mortality in Undiagnosed Celiac Disease” in Gastroenterology PubMed Cyrex Laboratories EnteroLab New York Times Article, May 1950 “Economic Benefits of Increased Diagnosis of Celiac Disease in a National Managed Care Population in the United States” in the Journal of Insurance Medicine “Celiac Disease Could be a Frequent Disease in Mexico: Prevalence of Tissue Transglutaminase Antibody in Healthy Blood Donors” in the Journal of Clinical Gastroenterology “Celiac Disease in African-Americans” in Digestive Diseases and Sciences “Coeliac Disease” in The Lancet Connect with Nadine: Instagram Facebook Contact via Email ‘Your Skin on Gluten’ on YouTube Melodies of the Danube Gluten-Free Cruise with Nadine Books by Nadine: Dough Nation: A Nurse's Memoir of Celiac Disease from Missed Diagnosis to Food and Health Activism
This week we review 1) Buprenorphine for the treatment of Neonatal Abstinence Syndrome: Kraft, Walter K., et al. "Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome." New England Journal of Medicine (2017). 2) Outcomes of FMT for C. difficile infections in IBD: Meighani, Alireza, et al. "Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease." Digestive Diseases and Sciences (2017): 1-6. 3) Vaccination During Pregnancy: Baxter, Roger, et al. "Effectiveness of vaccination during pregnancy to prevent infant pertussis." Pediatrics (2017): e20164091. 4) The Desire for Limb Amputation: Upadhyaya, Mihir A., and Henry A. Nasrallah. "The intense desire for healthy limb amputation: A dis-proprioceptive neuropsychiatric disorder." Annals of Clinical Psychiatry 29.2 (2017): 125-132. 5) A New Drug For ALS: Grady, Denise. "A Second Drug Is Approved to Treat A.L.S." The New York Times. The New York Times, 05 May 2017. Web. 07 May 2017. Welcome to TalkingMed, where we discuss current medical news. Contact: talkingmedpodcast@gmail.com Twitter: @TalkingMedPod Song credit: Night Owl by Broke For Free from the Free Music Archive, used under CCBY Attribution License, modified from the original. Disclaimer: The information presented on this podcast are our own personal views, opinions, and research on the subject matter and do not represent those of our institution or our department. Anything discussed on this podcast should not be considered medical advice. Please contact a professional if you have any medical concerns. All content found on TalkingMed, including text, images, audio, or other formats were created for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have learned it from TalkingMed. Under no circumstances shall Vivek, Stephen, TalkingMed, any guests or contributors to the podcast or blog, or any employees, associates, or affiliates of TalkingMed be responsible for damages arising from use of the podcast or blog. This podcast or blog should not be used in any legal capacity whatsoever, including but not limited to establishing “standard of care” in a legal sense or as a basis for expert witness testimony. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast or blog. You hereby acknowledge that nothing contained on TalkingMed shall constitute financial, investment, legal and/or other professional advice and that no professional relationship of any kind is created between you and the TalkingMed. You hereby agree that you shall not make any financial, investment, legal and/or other decision based in whole or in part on anything contained on TalkingMed. Nothing on TalkingMed or included as a part of TalkingMed should be construed as an attempt to offer or render a medical opinion or otherwise engage in the practice of medicine. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately. The content may contain health- or medical-related materials or discussions regarding sexually explicit disease states. If you find these materials offensive, you may not want to use this content.
Digestive diseases and naturopathic medicine Part 2
Digestive diseases and naturopathic medicine Part 1
Thank you for listening to this podcast, where Frontline Gastroenterology Trainee Editor Dr Philip Smith talks to Professor Edward Loftus, Professor of Gastroenterology and IBD at the Mayo Clinic, Rochester, Minnesota, USA. The podcast is an accompaniment to the Frontline Gastroenterology Twitter Debate (#FGDebate) held on Monday 11th May 2015, at 9-10pm GMT entitled, 'Frontline IBD: Hot topics in IBD’. For a summary of the debate please visit the storify page: https://storify.com/FrontGastro_BMJ/frontline-ibd-hot-topics-in-ibd The purpose of the podcast is to 'fill any gaps' the #FGDebate may have left. Professor Loftus has also provided the slides he used in #FGDebate to help those interested in the hot topics he covered. We hope you enjoy this and that it is informative. View the slides: https://drive.google.com/folderview?id=0B2aZuY6foZ0wSEprMkdQQVB2Qzg&usp=sharing Don't miss the next Special DDW Twitter #FGDebate with Dr Andreas Cardenas, Staff Member of the Institute of Digestive Diseases and Metabolism at the Hospital Clinic and University of Barcelona and Associate Editor for Frontline Gastroenterology, on Tuesday 9th June 2015, at 8-9pm GMT and will discuss, "Frontline Hepatology: complications with cirrhosis focusing on portal hypertension"
Mairi McLean talks to Emeran Mayer, Oppenheimer Center for Neurobiology of Stress, Division of Digestive Diseases, UCLA, about his paper: An update on the use and investigation of probiotics in health and disease.Read the full paper here: http://bit.ly/11ghKss
Host: Matt Birnholz, MD Over 15,000 gastrointestinal healthcare professionals attended the meeting in Chicago, May 30 - June 4, 2009. These highlights showcase the latest research and advances in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.
© 2020-2025 Ivy Podcast Discovery LLC
